{"meta":{"query_hash":"5ec910aabd7a","filters":{"venue":"Anti-Cancer Drugs"},"cohort_total":79,"direct_labels_cover":1,"predictions_cover":79,"exported":79,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5ec910aabd7a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Anti-Cancer+Drugs"},"results":[{"id":"W19262372","doi":"10.1097/cad.0b013e328329977f","title":"(Dis)orderly development in the North: Resistance and rule in the Northern Boreal Initiative (Ontario).","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Canadian Identity and History","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Resistance (ecology); Boreal; Geography; Ecology; Archaeology; Biology","score_opus":0.016674828828665698,"score_gpt":0.24672583713295526,"score_spread":0.23005100830428957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19262372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.927148,0.0010691568,9.3587215e-7,0.008134863,0.00006813241,0.00020684052,0.00001168515,0.0000075792263,0.0633528],"genre_scores_gemma":[0.9941632,0.0005740098,0.000039190272,0.0019779694,0.00013389546,0.00006564883,0.000006112211,0.0000056502804,0.003034318],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988621,0.00016481476,0.00018029167,0.00018437162,0.00032687225,0.0002815898],"domain_scores_gemma":[0.9996426,0.00008981549,0.00006340341,0.00012625809,0.00003665313,0.00004126862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060301967,0.00008215535,0.00011476585,0.00012938761,0.0007173778,0.00020102969,0.00033222858,0.000045494628,0.00010409174],"category_scores_gemma":[0.000020439824,0.00006933012,0.000024950548,0.00036637933,0.00036130095,0.00024278332,0.000016737562,0.00022058873,0.000023593018],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011904092,0.00006051942,0.2157506,0.0000076854185,0.000008807534,0.000012089291,0.75354457,0.0000062568033,6.6904875e-7,0.0015049735,0.0054547833,0.02363714],"study_design_scores_gemma":[0.00014582688,0.0000020791952,0.45376056,0.000013252634,0.0000028670934,1.2576763e-7,0.009244829,3.4134618e-7,7.7066153e-7,0.000106704196,0.53665453,0.00006809826],"about_ca_topic_score_codex":0.8623969,"about_ca_topic_score_gemma":0.99996966,"teacher_disagreement_score":0.74429977,"about_ca_system_score_codex":0.00094510696,"about_ca_system_score_gemma":0.0015281165,"threshold_uncertainty_score":0.55175626},"labels":[],"label_agreement":null},{"id":"W1963631227","doi":"10.1097/cad.0b013e3282f46aec","title":"A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients","year":2008,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Hôpital Saint-François d'Assise","funders":"","keywords":"Gemcitabine; Medicine; Regimen; Internal medicine; Vinorelbine; Oxaliplatin; Refractory (planetary science); Gastroenterology; Chemotherapy; Adverse effect; Oncology; Surgery; Cancer; Colorectal cancer","score_opus":0.02533042115458789,"score_gpt":0.29155552318333233,"score_spread":0.26622510202874444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963631227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729484,0.0003247276,3.5551656e-7,0.00012917831,0.0001977317,0.0010775763,0.000013048384,0.000037188733,0.0009253263],"genre_scores_gemma":[0.99804384,0.00051397394,0.0000949457,0.00034566797,0.0000668128,0.00023201779,0.000017873592,0.00003805326,0.00064683927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981671,0.00007910929,0.00053448166,0.00043560105,0.0004372557,0.00034647546],"domain_scores_gemma":[0.9989445,0.00011533011,0.00023968054,0.00043828273,0.00014713364,0.000115039424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011474165,0.00024771036,0.0006285788,0.0002006772,0.00007667195,0.000006715387,0.000112710586,0.000086082626,0.000119799035],"category_scores_gemma":[0.000056292585,0.00018221403,0.00009910416,0.00029806656,0.00006447515,0.00011648862,0.00006978633,0.0000817106,0.000022990458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016843398,0.010304583,0.9632279,0.000047906236,0.0002456059,0.00026608404,0.011456745,0.0000062358895,0.00012266201,0.0000028451036,0.0006332496,0.012001801],"study_design_scores_gemma":[0.043835547,0.0022541801,0.9479571,0.00029946782,0.0001402093,0.000004431767,0.0022540854,0.00006106261,0.0019485259,9.853097e-7,0.0010620032,0.00018240856],"about_ca_topic_score_codex":0.0033937858,"about_ca_topic_score_gemma":0.0002498882,"teacher_disagreement_score":0.04215121,"about_ca_system_score_codex":0.00044653055,"about_ca_system_score_gemma":0.00021780799,"threshold_uncertainty_score":0.74304724},"labels":[],"label_agreement":null},{"id":"W1963819705","doi":"10.1097/cad.0b013e328341185b","title":"Inhibiting aberrant Stat3 function with molecular therapeutics","year":2010,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto","funders":"","keywords":"STAT3; STAT protein; Cancer research; Downregulation and upregulation; Biology; Multiple myeloma; Signal transduction; Cell biology; Immunology; Gene; Genetics","score_opus":0.04739348485247957,"score_gpt":0.3524562118507138,"score_spread":0.3050627269982342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963819705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013856058,0.99240595,0.0005636324,0.00015572236,0.00066400354,0.0007845882,0.00007780922,0.00012497866,0.0038377142],"genre_scores_gemma":[0.0018563858,0.99510443,0.00021572402,0.00068701245,0.00067111076,0.00015538113,0.00023692977,0.00015047805,0.000922541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821264,0.000049841652,0.0005190172,0.000495526,0.00036320105,0.00035980178],"domain_scores_gemma":[0.9987545,0.00006339893,0.00041507027,0.00044378507,0.00020606886,0.00011714795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014902162,0.0004674408,0.0012796622,0.00020880904,0.00012895312,0.000060530252,0.00010531396,0.00029231366,0.0003885795],"category_scores_gemma":[0.000008922905,0.00031974728,0.00044720576,0.0003601452,0.000081945625,0.00008868273,0.000034584275,0.0012842789,0.00008906252],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003275907,0.000114503426,0.000011719869,0.004236996,0.00063073187,0.00003476143,0.00012337198,0.000002177564,0.0036681755,0.00012624056,0.00035183356,0.99066675],"study_design_scores_gemma":[0.00050358096,0.00020506665,0.0000042533666,0.015501678,0.0032260602,0.00010745144,0.00005754159,0.000016102342,0.0021658402,0.000008339046,0.9778382,0.00036588192],"about_ca_topic_score_codex":0.00015836315,"about_ca_topic_score_gemma":0.00002349962,"teacher_disagreement_score":0.99030083,"about_ca_system_score_codex":0.00011163669,"about_ca_system_score_gemma":0.0006218258,"threshold_uncertainty_score":0.99992543},"labels":[],"label_agreement":null},{"id":"W1966425626","doi":"10.1097/00001813-200311000-00001","title":"Doxycycline and other tetracyclines in the treatment of bone metastasis","year":2003,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Bone health and treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Doxycycline; Prostate cancer; Cancer research; Medicine; Matrix metalloproteinase; Metastasis; Breast cancer; Tetracycline; Cancer; Cancer cell; Osteoclast; Minocycline; Bone metastasis; Matrix metalloproteinase inhibitor; Oncology; Internal medicine; Biology; Antibiotics; Microbiology","score_opus":0.09369714820908856,"score_gpt":0.4241381933555619,"score_spread":0.3304410451464733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966425626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032508362,0.99361295,4.088462e-7,0.00028208873,0.00013959286,0.0016137259,0.0002043308,0.000011797306,0.00088427577],"genre_scores_gemma":[0.00047445207,0.99698055,0.00017203912,0.0005042263,0.000097806194,0.0003869415,0.000057250785,0.00005216866,0.0012745777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806076,0.00017497175,0.00081050536,0.00039152792,0.000236219,0.00032601133],"domain_scores_gemma":[0.99881357,0.0002035268,0.0003723506,0.00047257572,0.000031465806,0.00010654078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023307686,0.00042711274,0.0023811758,0.00021717674,0.000045302208,0.000009695358,0.00006408947,0.00018523473,0.00010130421],"category_scores_gemma":[0.000012578539,0.00021786448,0.00037415838,0.0004110345,0.00009842428,0.000029090892,0.000008423603,0.00016811346,0.000017810155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023937822,0.001150644,0.0022558663,0.0063077887,0.0004511766,0.00004013262,0.00032390803,4.051509e-8,2.4363587e-7,0.000024532197,0.00023173123,0.98919],"study_design_scores_gemma":[0.002062151,0.00030811335,0.00031673635,0.0036021615,0.0026859972,0.00006131442,0.00005572487,4.977744e-7,0.000010114678,0.000010245638,0.9907359,0.00015108325],"about_ca_topic_score_codex":0.001701575,"about_ca_topic_score_gemma":0.0002100584,"teacher_disagreement_score":0.99050415,"about_ca_system_score_codex":0.00011718362,"about_ca_system_score_gemma":0.0002765818,"threshold_uncertainty_score":0.8884255},"labels":[],"label_agreement":null},{"id":"W1975493627","doi":"10.1097/cad.0b013e328333d679","title":"Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sunitinib; Sorafenib; Platelet-derived growth factor receptor; Cancer research; Medicine; Tyrosine kinase; Vascular endothelial growth factor; Pathophysiology; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Recall; Cancer; Pharmacology; Internal medicine; Oncology; Receptor; VEGF receptors; Growth factor; Psychology; Hepatocellular carcinoma","score_opus":0.011594659969088232,"score_gpt":0.2769148304306642,"score_spread":0.265320170461576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975493627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97724384,0.012707624,0.00015717247,0.0083040735,0.00019892908,0.00066536415,0.00010644748,0.00021844066,0.00039810457],"genre_scores_gemma":[0.98559535,0.0066883825,0.0009984103,0.004969948,0.00028180855,0.000022277063,0.00024004668,0.000048277878,0.001155495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983213,0.00007876694,0.00047227496,0.00042781344,0.00030190387,0.00039795786],"domain_scores_gemma":[0.9990555,0.00006691415,0.00020732971,0.00031026517,0.0001256728,0.00023428381],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019074463,0.00029489858,0.0005007819,0.00015084547,0.00013309685,0.000046804096,0.00008784081,0.0002570641,0.00028641016],"category_scores_gemma":[0.00008177778,0.00028600555,0.00010208764,0.0004068446,0.00010544255,0.0002451777,0.000017525146,0.00035245987,0.000028562143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023074048,0.0008499565,0.006065916,0.00012272462,0.0001852476,0.000044293385,0.0026601593,0.000008543545,0.5816472,0.000023855351,0.07463315,0.3335282],"study_design_scores_gemma":[0.013104309,0.00023518137,0.03682808,0.00039382715,0.00017548243,0.000032008,0.0001478309,0.0012140718,0.90245354,0.00005498548,0.0448524,0.0005082577],"about_ca_topic_score_codex":0.00044562697,"about_ca_topic_score_gemma":0.000020259507,"teacher_disagreement_score":0.33301994,"about_ca_system_score_codex":0.00014470417,"about_ca_system_score_gemma":0.00010310425,"threshold_uncertainty_score":0.99995923},"labels":[],"label_agreement":null},{"id":"W1977609704","doi":"10.1097/cad.0b013e32832f4aa8","title":"Methotrexate-induced apoptosis is enhanced by altered expression of methylenetetrahydrofolate reductase","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Methylenetetrahydrofolate reductase; TUNEL assay; Apoptosis; Methotrexate; Terminal deoxynucleotidyl transferase; Hyperhomocysteinemia; Methyltransferase; Pharmacology; Chemistry; Homocysteine; Molecular biology; Biology; Endocrinology; Internal medicine; Cancer research; Methylation; Biochemistry; Medicine; DNA; Genotype","score_opus":0.026803602711573768,"score_gpt":0.35476926397037,"score_spread":0.3279656612587962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977609704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929794,0.0012720997,0.00009326409,0.0019522307,0.00018201156,0.00045096368,0.00006822337,0.00006622882,0.0029355853],"genre_scores_gemma":[0.9922091,0.0029214965,0.0009803593,0.0008713488,0.00017396013,0.000028459144,0.000056083274,0.000038679398,0.0027205579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747616,0.00012600361,0.00052705524,0.0005942796,0.0006886122,0.00058786676],"domain_scores_gemma":[0.9985562,0.000071346585,0.00020167815,0.0006687286,0.00022882027,0.00027325028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036285204,0.00030067816,0.0007140723,0.000250865,0.00009780691,0.000022432274,0.00025594298,0.00020780957,0.0007418352],"category_scores_gemma":[0.0000547326,0.0002464515,0.00023549184,0.00063433824,0.00007576454,0.00021321548,0.000056931935,0.0003860309,0.000050043876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026938302,0.00030147337,0.00009107868,0.00008843835,0.00010539584,0.0000013569721,0.0010241389,0.0000013513693,0.94012225,0.000004469854,0.015389948,0.042600725],"study_design_scores_gemma":[0.0020262797,0.00053653144,0.00073419634,0.00030142578,0.00011649697,0.0000013224321,0.00019718337,0.00007784574,0.9932344,0.000056517536,0.0024624828,0.000255313],"about_ca_topic_score_codex":0.0004185708,"about_ca_topic_score_gemma":0.000001173968,"teacher_disagreement_score":0.053112164,"about_ca_system_score_codex":0.00008259935,"about_ca_system_score_gemma":0.00015161303,"threshold_uncertainty_score":0.99999875},"labels":[],"label_agreement":null},{"id":"W1977936920","doi":"10.1097/00001813-200411000-00005","title":"G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells: caveolin-1 as a marker of cytotoxicity","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"","keywords":"Paclitaxel; Caveolin 1; A549 cell; Cytotoxicity; Cell cycle; Caveolae; Cytotoxic T cell; Apoptosis; Cancer research; Cell; Lung cancer; Cancer cell; Cell culture; Chemistry; Pharmacology; Cancer; Biology; Cell biology; Medicine; Internal medicine; In vitro; Biochemistry","score_opus":0.005456338230907018,"score_gpt":0.26444046240751806,"score_spread":0.25898412417661104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977936920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812284,0.01644626,0.00018819426,0.00028745242,0.00028572459,0.00038758176,0.00026108642,0.000021454394,0.000893838],"genre_scores_gemma":[0.98646677,0.01072698,0.00013994114,0.0004982976,0.00033647328,0.00015973988,0.00010020371,0.000062638035,0.0015089619],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760574,0.000074809504,0.0005725968,0.0007712202,0.00037043955,0.0006052031],"domain_scores_gemma":[0.99883586,0.000021335034,0.00030588676,0.0004976591,0.00016809632,0.00017114248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025167206,0.0004062891,0.0004835011,0.000111902824,0.000107319844,0.000032218308,0.00042560164,0.0004109674,0.00018553367],"category_scores_gemma":[0.000037136546,0.00038780208,0.00018973643,0.0003007289,0.00020770723,0.000022913571,0.00022254053,0.0002990118,0.000009381234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017107469,0.00029215694,0.005609939,0.00023029202,0.000078717996,0.000008805047,0.0005962249,0.0003816607,0.9904642,0.000012588675,0.0015912211,0.0005631117],"study_design_scores_gemma":[0.0018527162,0.00008729923,0.0007899683,0.00029645447,0.00004778334,0.0000048148922,0.0003748924,0.00002562365,0.99212253,0.00010616056,0.003811336,0.00048043503],"about_ca_topic_score_codex":0.0037457095,"about_ca_topic_score_gemma":0.0005278319,"teacher_disagreement_score":0.005719281,"about_ca_system_score_codex":0.00009993592,"about_ca_system_score_gemma":0.0005489126,"threshold_uncertainty_score":0.99985737},"labels":[],"label_agreement":null},{"id":"W1978585178","doi":"10.1097/00001813-200606000-00014","title":"Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Doxorubicin; Cardiotoxicity; Anthracycline; Internal medicine; Metastatic breast cancer; Cyclophosphamide; Breast cancer; Adjuvant; Randomization; Oncology; Cancer; Chemotherapy; Surgery; Randomized controlled trial; Gastroenterology","score_opus":0.008634561448113807,"score_gpt":0.2784867038953679,"score_spread":0.2698521424472541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978585178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214184,0.0004980911,0.000029284372,0.0004458914,0.00008272074,0.0027924755,0.0039184163,0.000025529596,0.00006575514],"genre_scores_gemma":[0.99809253,0.0004481512,0.00022642723,0.00005219192,0.000053227286,0.00032919744,0.0005140632,0.000060975908,0.00022322303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551034,0.00053000153,0.0016962324,0.00095733925,0.0006584344,0.0006476608],"domain_scores_gemma":[0.9963832,0.00040889447,0.0014956675,0.00058606546,0.00094128406,0.00018490806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006150993,0.0006639788,0.003225038,0.0011442165,0.00007354261,0.000011086433,0.00017589016,0.00012243596,0.00015007636],"category_scores_gemma":[0.00003543459,0.00049036305,0.00040947314,0.002897575,0.00046535043,0.00017170003,0.000038474416,0.00023848376,7.8237025e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.153958,0.005867637,0.7333685,0.00023705386,0.0040235175,0.0000989336,0.0011766454,0.008109841,0.09275468,0.0000014479888,0.00003979685,0.000363938],"study_design_scores_gemma":[0.06380585,0.0038795648,0.71233255,0.0008166271,0.0033614356,0.000006069903,0.00015775267,0.004594277,0.210715,0.000002581919,0.000011886858,0.00031639764],"about_ca_topic_score_codex":0.071325615,"about_ca_topic_score_gemma":0.03148451,"teacher_disagreement_score":0.11796031,"about_ca_system_score_codex":0.0013153253,"about_ca_system_score_gemma":0.0010449756,"threshold_uncertainty_score":0.9997548},"labels":[],"label_agreement":null},{"id":"W1984697909","doi":"10.1097/cad.0b013e3282a213ce","title":"Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Micropharma (Canada)","funders":"National Institute of Allergy and Infectious Diseases; Korea Research Institute of Standards and Science","keywords":"Doxorubicin; Internalization; Cancer research; Cytotoxicity; In vitro; In vivo; Pharmacology; Cancer cell; Liposome; Chemistry; Medicine; Cancer; Cell; Chemotherapy; Biology; Biochemistry; Internal medicine","score_opus":0.008670695760990747,"score_gpt":0.2795823270588681,"score_spread":0.2709116312978774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984697909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974228,0.0010848854,0.00057662226,0.0001850374,0.00006694627,0.0002226191,0.00001303086,0.000031838106,0.0003961932],"genre_scores_gemma":[0.99833816,0.0006745811,0.00018102597,0.00029269492,0.00011056559,0.0000048705338,0.000020456628,0.000022518327,0.00035509656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986637,0.000045584555,0.00041381002,0.00031254307,0.00028418924,0.0002801605],"domain_scores_gemma":[0.9993925,0.00008681751,0.00019289153,0.00012164058,0.00007874478,0.00012742038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003772841,0.00017610868,0.00043423538,0.0004695924,0.00006133555,0.000032226304,0.00005505229,0.000092642025,0.00006567188],"category_scores_gemma":[0.000040423274,0.0001615606,0.00006524766,0.00044033694,0.00008080475,0.00020703586,0.000057993606,0.00017018005,0.0000058739506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006787445,0.00008956778,0.081978396,0.00052165944,0.00005030173,0.000055577344,0.00085012196,0.000011974661,0.9142233,0.00006695224,0.000102694605,0.001981556],"study_design_scores_gemma":[0.0021588404,0.00006643993,0.04020889,0.0034726376,0.00008764963,0.000012264182,0.00031337008,0.0019007876,0.95146805,0.00001209866,0.00013314103,0.00016581819],"about_ca_topic_score_codex":0.00029707953,"about_ca_topic_score_gemma":0.000060857834,"teacher_disagreement_score":0.041769505,"about_ca_system_score_codex":0.000051952706,"about_ca_system_score_gemma":0.00003417426,"threshold_uncertainty_score":0.658825},"labels":[],"label_agreement":null},{"id":"W1984891600","doi":"10.1097/cad.0b013e328313e172","title":"Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts","year":2008,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Doxorubicin; Glioma; Radiosensitizer; Biodistribution; Medicine; Chemotherapy; Pharmacology; Cancer research; U87; Radiation therapy; Oncology; Chemistry; Internal medicine; In vitro","score_opus":0.028189836916229755,"score_gpt":0.28970212617144114,"score_spread":0.2615122892552114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984891600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945256,0.0018424636,0.000001181685,0.0016073012,0.0002441284,0.00040788707,0.000015212549,0.000038460432,0.0013177376],"genre_scores_gemma":[0.99763554,0.0012996189,0.0001260648,0.00044950988,0.00016351002,0.000057930378,0.00001625257,0.000033452307,0.00021813648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985249,0.00004119929,0.00042396467,0.00035891696,0.00028026206,0.00037074025],"domain_scores_gemma":[0.9991805,0.000058728427,0.00016107663,0.00036044384,0.000095072726,0.00014415795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009024651,0.00023024184,0.0006025674,0.00032372502,0.000049240476,0.000007517026,0.0000909786,0.000097525546,0.00016758464],"category_scores_gemma":[0.000027518943,0.00018254781,0.0001845009,0.0004875035,0.00015780138,0.00007743092,0.000053309926,0.00013460725,0.000092733855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054941716,0.0025942083,0.4096271,0.00016662368,0.0004513646,0.0069080363,0.003807429,0.000017206423,0.5626161,0.0009228513,0.0039797225,0.0083599165],"study_design_scores_gemma":[0.005291978,0.00037715232,0.203654,0.0006378401,0.00011015912,0.00065023033,0.00027982992,0.00003695346,0.7868343,0.000025621788,0.001904755,0.00019715674],"about_ca_topic_score_codex":0.0023942909,"about_ca_topic_score_gemma":0.0001940094,"teacher_disagreement_score":0.2242182,"about_ca_system_score_codex":0.00010692345,"about_ca_system_score_gemma":0.00014400671,"threshold_uncertainty_score":0.74440837},"labels":[],"label_agreement":null},{"id":"W1985842761","doi":"10.1097/cad.0000000000000145","title":"Integrins","year":2014,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"China Scholarship Council; McGill University Health Centre","keywords":"Integrin; Extracellular matrix; Cell biology; Cell adhesion; Signal transduction; Cell surface receptor; Intracellular; Motility; Cell adhesion molecule; Receptor; Cancer research; Cell; Biology; Biochemistry","score_opus":0.0640475224849201,"score_gpt":0.4258113649242002,"score_spread":0.36176384243928006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985842761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002785216,0.97910863,0.000028731754,0.00021198759,0.00032948828,0.0009415386,0.000027689128,0.00009231751,0.01923175],"genre_scores_gemma":[0.000019619963,0.96916944,0.00010207692,0.00035682248,0.00082626805,0.00020847477,0.00014275976,0.00014305777,0.029031463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736756,0.00015477095,0.0005973453,0.0006651124,0.0006710015,0.0005442274],"domain_scores_gemma":[0.99821824,0.00016880587,0.00021876399,0.00093528227,0.00015111764,0.00030778183],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003320248,0.00046945512,0.0024644637,0.00037265525,0.000063883715,0.00004107699,0.00040948653,0.00039690762,0.002429541],"category_scores_gemma":[0.00009988984,0.00033477414,0.0008598777,0.0005272599,0.00013049557,0.000032224656,0.00024485786,0.0011765256,0.003579583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005348586,0.000060226404,0.000016590047,0.025465226,0.00019154564,0.000035812747,0.0000244316,4.0884267e-8,0.00001003943,0.00007332465,0.021175122,0.9529423],"study_design_scores_gemma":[0.00033784332,0.00006257359,0.000010418323,0.017288143,0.000648306,0.000036504243,0.000010416545,0.0000061959768,0.000060885686,0.0000048460884,0.9812302,0.00030366218],"about_ca_topic_score_codex":0.00014398807,"about_ca_topic_score_gemma":0.0000073714477,"teacher_disagreement_score":0.9600551,"about_ca_system_score_codex":0.00029800338,"about_ca_system_score_gemma":0.00094644586,"threshold_uncertainty_score":0.9999104},"labels":[],"label_agreement":null},{"id":"W1987526635","doi":"10.1097/cad.0b013e3282eea257","title":"Apoptotic pathway induced by noscapine in human myelogenous leukemic cells","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Iran University of Medical Sciences","keywords":"Noscapine; Apoptosis; DNA fragmentation; Phosphatidylserine; Poly ADP ribose polymerase; Chemistry; K562 cells; Caspase; Cell biology; Molecular biology; Programmed cell death; Cancer research; Biology; Biochemistry; Alkaloid; DNA; Polymerase","score_opus":0.008083415128999077,"score_gpt":0.25188574934280084,"score_spread":0.24380233421380176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987526635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969939,0.0010166857,0.0005832749,0.000044096752,0.00027887736,0.00021201489,0.000014606985,0.000015614232,0.0008409174],"genre_scores_gemma":[0.9968134,0.0005970877,0.0000896284,0.0002629136,0.00024869028,0.000012145633,0.0001681068,0.000032226926,0.0017757893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880683,0.00002509231,0.00027455844,0.0003801029,0.00013722182,0.00037618598],"domain_scores_gemma":[0.9995128,0.0000056541585,0.00009604904,0.00026792145,0.000042257037,0.00007534905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025617876,0.00017850213,0.00017541827,0.00007193608,0.000087588734,0.000015974087,0.00015548906,0.0002234674,0.00005035174],"category_scores_gemma":[0.0000035284409,0.00017415723,0.000071437025,0.00013594929,0.000035482484,0.000004776398,0.00006177476,0.00011501123,0.000012152014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018595792,0.000073620606,0.000263111,0.000016593409,0.00001692034,0.0000024862152,0.00012880129,0.00004803334,0.9893147,0.00006115472,0.00038659506,0.009669426],"study_design_scores_gemma":[0.00076099084,0.00011497096,0.0023204884,0.000018857258,0.000008297582,0.0000017653706,0.00008989685,0.000030763862,0.9873284,0.00004440628,0.009042387,0.00023874264],"about_ca_topic_score_codex":0.00043420057,"about_ca_topic_score_gemma":0.00018653071,"teacher_disagreement_score":0.009430683,"about_ca_system_score_codex":0.000058458838,"about_ca_system_score_gemma":0.000062741805,"threshold_uncertainty_score":0.71019256},"labels":[],"label_agreement":null},{"id":"W1989545813","doi":"10.1097/01.cad.0000224442.78211.27","title":"Kinamycins A and C, bacterial metabolites that contain an unusual diazo group, as potential new anticancer agents: antiproliferative and cell cycle effects","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Manitoba","funders":"National Cancer Institute","keywords":"Topoisomerase; Chinese hamster ovary cell; Cell cycle; Diazo; Cell growth; Biochemistry; Biology; DNA synthesis; DNA gyrase; Cell; Mechanism of action; Chemistry; DNA; In vitro; Receptor","score_opus":0.005652982179236384,"score_gpt":0.2463329000675111,"score_spread":0.24067991788827472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989545813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141324,0.0059593134,0.0010962947,0.00016092157,0.0005256853,0.00043586458,0.000079282705,0.000024185776,0.00030521236],"genre_scores_gemma":[0.99204654,0.0048001707,0.00026795204,0.00082838687,0.0011865828,0.000043622684,0.00016470235,0.000054794436,0.00060726044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983867,0.00009662276,0.00020670718,0.00067255564,0.00019290445,0.00044453176],"domain_scores_gemma":[0.9993385,0.00001389882,0.00012715053,0.00026754176,0.00005460939,0.00019831241],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012715602,0.0003362442,0.00036664007,0.000058063863,0.00017239864,0.00016159333,0.00014086731,0.00017535668,0.000043364973],"category_scores_gemma":[0.000004472259,0.00031763484,0.00008553537,0.00008084698,0.0001356561,0.00003596241,0.0001309386,0.000108713015,0.0000029429675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035585795,0.00012527942,0.0018765872,0.000046275454,0.00010855045,0.000008722285,0.00021656648,0.000012063469,0.9895836,0.00091054436,0.00024039949,0.00651557],"study_design_scores_gemma":[0.0036604581,0.0005278359,0.013819995,0.000027655888,0.00017543464,0.000011852829,0.00014761824,0.00017243356,0.9654715,0.000868332,0.0146476785,0.0004692131],"about_ca_topic_score_codex":0.002401128,"about_ca_topic_score_gemma":0.0003273997,"teacher_disagreement_score":0.024112092,"about_ca_system_score_codex":0.00002080588,"about_ca_system_score_gemma":0.00012263539,"threshold_uncertainty_score":0.9999276},"labels":[],"label_agreement":null},{"id":"W1999564272","doi":"10.1097/cad.0b013e3283287c20","title":"Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Prodrug; Pharmacokinetics; Pharmacology; Nicotinamide; Bolus (digestion); Therapeutic index; Chemistry; Mechanism of action; Medicine; In vitro; Drug; Internal medicine; Biochemistry; Enzyme","score_opus":0.014539764167131096,"score_gpt":0.30485593516102777,"score_spread":0.29031617099389667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999564272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577916,0.001445446,0.00016492393,0.0013951556,0.00014078504,0.00034910158,0.000017502021,0.000011039886,0.0006968849],"genre_scores_gemma":[0.9972348,0.00035416178,0.00046325888,0.0006491199,0.00017777712,0.000031968146,0.000031653628,0.000016962565,0.0010403042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850076,0.000059893977,0.00036632628,0.00041908675,0.0003166456,0.00033726872],"domain_scores_gemma":[0.9992705,0.000009324667,0.00007144794,0.00042508446,0.00011810009,0.000105534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024662935,0.00017658387,0.0001944931,0.000019256971,0.0001048131,0.000015053513,0.0004245464,0.0001697672,0.000030974414],"category_scores_gemma":[0.0000549619,0.00012495244,0.00018394038,0.00015323717,0.0001500608,0.0000037594655,0.00012282617,0.00020850857,0.000006712698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010684771,0.00023024202,0.0011642041,0.00003149959,0.000045005407,5.295729e-7,0.0001411337,0.0000036870479,0.9608031,0.000039679122,0.0017303319,0.03570372],"study_design_scores_gemma":[0.00060862483,0.00009119721,0.0054984307,0.000053159587,0.000014223607,0.0000013368066,0.000026349748,0.0000067794676,0.9554971,0.000029764573,0.038002633,0.0001704149],"about_ca_topic_score_codex":0.000018381746,"about_ca_topic_score_gemma":0.000017312264,"teacher_disagreement_score":0.0362723,"about_ca_system_score_codex":0.000020417172,"about_ca_system_score_gemma":0.0003392555,"threshold_uncertainty_score":0.5095413},"labels":[],"label_agreement":null},{"id":"W2005482433","doi":"10.1097/cad.0b013e32832cb8bc","title":"Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Clonogenic assay; Ionizing radiation; Comet assay; Cell cycle; Cell cycle checkpoint; Apoptosis; Cancer research; Epidermal growth factor receptor; DNA damage; Tyrosine kinase; Chemistry; DNA repair; Molecular biology; Biology; Irradiation; Signal transduction; Cell biology; Receptor; DNA; Biochemistry","score_opus":0.009402137015691033,"score_gpt":0.26894242854634487,"score_spread":0.25954029153065383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005482433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946818,0.002802046,0.0013391236,0.0003263155,0.00024749726,0.00010801635,0.000009626586,0.0000098961755,0.00047568002],"genre_scores_gemma":[0.9958941,0.0029868288,0.00027633848,0.00046115665,0.0001934651,0.00000820352,0.000043320702,0.000012630678,0.0001239554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934,0.000024081033,0.0001708023,0.00022663483,0.00008658849,0.00015189593],"domain_scores_gemma":[0.99964285,0.0000050363724,0.0001249462,0.0001297035,0.0000574788,0.00004000651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010804263,0.00010607303,0.00012622474,0.000039713257,0.000057864905,0.000019099207,0.0000653499,0.00007434302,0.000012666423],"category_scores_gemma":[0.000008756937,0.00010964526,0.00005414547,0.00006992931,0.000021076094,0.000008340874,0.000025325058,0.000055427554,0.0000010084269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040879164,0.000027105609,0.00015165487,0.0000114396935,0.000031450283,2.7836617e-7,0.00016274757,0.00003633707,0.94641674,0.00019947819,0.00025971892,0.052662198],"study_design_scores_gemma":[0.0005049914,0.0001431358,0.0010195174,0.000026700518,0.000023436485,0.0000019557285,0.00018708332,0.00029548875,0.98301154,0.00012815911,0.014526556,0.00013140398],"about_ca_topic_score_codex":0.00006392168,"about_ca_topic_score_gemma":0.000010259621,"teacher_disagreement_score":0.05253079,"about_ca_system_score_codex":0.000019556248,"about_ca_system_score_gemma":0.000037285045,"threshold_uncertainty_score":0.4471204},"labels":[],"label_agreement":null},{"id":"W2006614996","doi":"10.1097/00001813-200010000-00007","title":"Irinotecan-associated pulmonary toxicity","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Irinotecan; Interstitial lung disease; Pulmonary toxicity; Pulmonary function testing; Adverse effect; Disease; Lung cancer; Internal medicine; Complication; Pneumonitis; Intensive care medicine; Clinical trial; Colorectal cancer; Cancer; Lung; Surgery","score_opus":0.009231034895599156,"score_gpt":0.2549069427323571,"score_spread":0.24567590783675794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006614996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874579,0.0013844987,0.00006818627,0.0003815483,0.00023558104,0.00014408503,0.000078587145,0.00003518202,0.010214467],"genre_scores_gemma":[0.9808085,0.004305429,0.000039773993,0.0020873512,0.0003296965,0.00003970487,0.00008993656,0.000035409495,0.01226419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989106,0.00003327121,0.00016868577,0.00038151865,0.00015443437,0.00035150954],"domain_scores_gemma":[0.9994784,0.000004322989,0.00005616451,0.000322911,0.000049933846,0.00008824174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010886768,0.00017825591,0.00016917958,0.000024459763,0.00011345556,0.000025323703,0.00021470731,0.00015987612,0.0010120171],"category_scores_gemma":[0.0000036212828,0.0001804921,0.00012277617,0.000116409785,0.000053071195,0.0000046256014,0.000047733494,0.00010094059,0.000057479985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007472512,0.00019511241,0.0004522588,0.000007936687,0.00010999137,0.000003578012,0.00006793363,0.00008116479,0.85412014,0.00007272034,0.0017385916,0.14307585],"study_design_scores_gemma":[0.0005354437,0.00013701078,0.0015345417,0.000019397161,0.000029313987,0.000004126681,0.000034064433,0.0001312067,0.70558155,0.00017075779,0.29150677,0.0003158382],"about_ca_topic_score_codex":0.00024205612,"about_ca_topic_score_gemma":0.00009217406,"teacher_disagreement_score":0.2897682,"about_ca_system_score_codex":0.000038090147,"about_ca_system_score_gemma":0.00009145939,"threshold_uncertainty_score":0.9999012},"labels":[],"label_agreement":null},{"id":"W2007222488","doi":"10.1097/00001813-200206000-00010","title":"DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"DNA repair; Nucleotide excision repair; Cell culture; Mechanism of action; Drug resistance; Cancer research; DNA; Biology; Cancer; Molecular biology; Chemistry; Genetics; In vitro","score_opus":0.024893951936866915,"score_gpt":0.2900982614699908,"score_spread":0.2652043095331239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007222488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151003,0.0023329656,0.00003385786,0.001731276,0.00024074453,0.0013134987,0.0001058808,0.000057563233,0.002674205],"genre_scores_gemma":[0.98964816,0.000159134,0.0016593481,0.0009314459,0.00045293616,0.0007990765,0.000015978005,0.000045461533,0.0062884404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975736,0.00018863198,0.0005047837,0.00062684383,0.0006613005,0.0004448446],"domain_scores_gemma":[0.9987286,0.000019451687,0.00035114767,0.0005850925,0.00026330302,0.000052424504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005833992,0.00030475992,0.00029227007,0.00006827772,0.00026280346,0.00004541259,0.00077775883,0.00009577289,0.000079724705],"category_scores_gemma":[0.000057254707,0.0002164209,0.00025098867,0.00047053394,0.00032240862,0.00003114653,0.00019545724,0.00026440262,0.0000037116786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063908425,0.0006393315,0.008047561,0.0003673161,0.00014913308,0.000007622757,0.00182385,0.00025004873,0.96664387,0.0009243556,0.019048808,0.0020342],"study_design_scores_gemma":[0.0010879728,0.000040139937,0.0068348553,0.00039287092,0.000042190342,0.000001885557,0.00022273096,0.00041225032,0.9091898,0.00016646735,0.08118418,0.00042464354],"about_ca_topic_score_codex":0.00052480836,"about_ca_topic_score_gemma":0.0022272996,"teacher_disagreement_score":0.062135372,"about_ca_system_score_codex":0.00006563181,"about_ca_system_score_gemma":0.00017951807,"threshold_uncertainty_score":0.8825388},"labels":[],"label_agreement":null},{"id":"W2008582463","doi":"10.1097/01.cad.0000190282.05748.63","title":"Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Medicine; Vomiting; Regimen; Nausea; Cisplatin; Doxorubicin; Internal medicine; Toxicity; Gastroenterology; Diarrhea; Chemotherapy; Phases of clinical research; Neutropenia","score_opus":0.008319956625518418,"score_gpt":0.3313097557740054,"score_spread":0.32298979914848697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008582463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628365,0.000287399,0.000013338075,0.00050710974,0.000083127255,0.0010070979,0.000059406953,0.000019852692,0.0017389917],"genre_scores_gemma":[0.99820817,0.00015654413,0.0007046519,0.00023133047,0.00009993461,0.000094668634,0.00005843188,0.00002375086,0.00042252953],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99892837,0.00001662238,0.0003362056,0.00025758552,0.00023909946,0.00022211175],"domain_scores_gemma":[0.99944556,0.000028928309,0.00015430062,0.00018718575,0.00009528702,0.00008874892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006210382,0.00015974266,0.00041455714,0.00012509419,0.00003951241,0.000007663895,0.00004223088,0.000038846545,0.00008052907],"category_scores_gemma":[0.0000134011325,0.00011858284,0.000038965558,0.00022591482,0.00007366627,0.00017421933,0.000016237476,0.00009547624,0.0000037201987],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0812384,0.0128958,0.34847018,0.0003764274,0.0007197035,0.000027575234,0.0076063187,0.00052254973,0.005880792,0.00036088767,0.0009576252,0.54094374],"study_design_scores_gemma":[0.7706677,0.006582714,0.1941483,0.00082122267,0.0005520883,0.0000026869536,0.00053279067,0.0003432971,0.022606276,0.00003588002,0.0032671788,0.0004398777],"about_ca_topic_score_codex":0.00019235004,"about_ca_topic_score_gemma":0.0000840501,"teacher_disagreement_score":0.6894293,"about_ca_system_score_codex":0.0001074349,"about_ca_system_score_gemma":0.00015377274,"threshold_uncertainty_score":0.48356676},"labels":[],"label_agreement":null},{"id":"W2010947980","doi":"10.1097/00001813-200203000-00007","title":"The doxorubicin cardioprotective agent dexrazoxane (ICRF-187) induces endopolyploidy in rat neonatal myocytes through inhibition of DNA topoisomerase II","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Topoisomerase; Doxorubicin; Myocyte; Cardiotoxicity; Pharmacology; Flow cytometry; Biology; Chemistry; Cell biology; DNA; Molecular biology; Biochemistry; Anthracycline; Chemotherapy","score_opus":0.01661729173243212,"score_gpt":0.2512402859184167,"score_spread":0.23462299418598456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010947980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852057,0.012684091,0.00014406293,0.0005766129,0.00043695414,0.000428086,0.000058470592,0.000011722322,0.0004542812],"genre_scores_gemma":[0.98606116,0.012388769,0.000053441738,0.00042354254,0.0002742832,0.00014905428,0.000026418496,0.000029647677,0.0005936644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862164,0.00007224206,0.00032058122,0.00040141205,0.00022590051,0.0003582038],"domain_scores_gemma":[0.99930626,0.00001929195,0.00016373499,0.00037372936,0.00008854978,0.000048417063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017270679,0.00022604674,0.0002624981,0.000046609242,0.00022186848,0.000026576845,0.00019266912,0.00014277746,0.000048777376],"category_scores_gemma":[0.000013505809,0.00018263023,0.00015211424,0.00020542725,0.00013424476,0.00001619819,0.00014922937,0.00016494715,0.0000047266813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090882524,0.000075193486,0.00006913512,0.000017535769,0.000083800696,0.0000042629854,0.001329097,0.000051482926,0.9757832,0.00033654663,0.00023724305,0.021921566],"study_design_scores_gemma":[0.001104809,0.00025116556,0.00007119444,0.000045106306,0.00002787041,0.000005693028,0.00091699115,0.000029267307,0.9632759,0.00031754508,0.033734083,0.00022036281],"about_ca_topic_score_codex":0.00066937075,"about_ca_topic_score_gemma":0.00038943772,"teacher_disagreement_score":0.033496838,"about_ca_system_score_codex":0.00006914168,"about_ca_system_score_gemma":0.000057970763,"threshold_uncertainty_score":0.7447445},"labels":[],"label_agreement":null},{"id":"W2011397767","doi":"10.1097/00001813-200302000-00001","title":"Neovastat—a novel antiangiogenic drug for cancer therapy","year":2003,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Angiogenesis; Medicine; Drug; Clinical trial; Matrix metalloproteinase; Matrix metalloproteinase inhibitor; Multiple myeloma; Pharmacology; Cancer; Lung cancer; Apoptosis; Cancer research; Vascular endothelial growth factor; Oncology; Internal medicine; Biology; VEGF receptors","score_opus":0.05688579399434322,"score_gpt":0.37250908454387416,"score_spread":0.3156232905495309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011397767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004202664,0.99253595,0.0006657995,0.00008602409,0.002399916,0.0016999673,0.0018060191,0.00004523937,0.00034081234],"genre_scores_gemma":[0.00009883329,0.9852437,0.00060779846,0.0009194215,0.002297793,0.0020895,0.00071096845,0.00034737214,0.007684659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963428,0.000118857984,0.00080102973,0.001440057,0.0003446763,0.0009525892],"domain_scores_gemma":[0.9977269,0.00006519389,0.00068281306,0.0010668857,0.0002733433,0.00018487418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003979874,0.0009827787,0.0017082156,0.00015851915,0.00020158228,0.00008924804,0.00090066245,0.0006531358,0.00024222926],"category_scores_gemma":[0.00002181403,0.0008761936,0.0016036268,0.0003986518,0.00017564143,0.000010588272,0.00012660834,0.00033050848,0.00002942037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051306513,0.0001496281,0.000026650214,0.003348001,0.0020663862,0.00000201005,0.00007552295,0.00003171125,0.006554243,0.00004083982,0.06121337,0.92644036],"study_design_scores_gemma":[0.0010957336,0.00008005614,0.0000013962195,0.0018995404,0.00057779776,0.00000998147,0.000013835122,0.000003804412,0.010577043,0.000009402406,0.9846465,0.0010849378],"about_ca_topic_score_codex":0.00025691857,"about_ca_topic_score_gemma":0.000071552444,"teacher_disagreement_score":0.9253554,"about_ca_system_score_codex":0.00017999593,"about_ca_system_score_gemma":0.0017498177,"threshold_uncertainty_score":0.9993689},"labels":[],"label_agreement":null},{"id":"W2011409049","doi":"10.1097/00001813-200602000-00007","title":"The combi-targeting concept: evidence for the formation of a novel inhibitor in vivo","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; McGill University; Royal Victoria Hospital","funders":"","keywords":"In vivo; Chemistry; In vitro; Acetylation; Cmax; Hydrolysis; Epidermal growth factor receptor; High-performance liquid chromatography; Biochemistry; Receptor; Pharmacology; Pharmacokinetics; Chromatography; Biology","score_opus":0.02588368228105015,"score_gpt":0.30137434649294514,"score_spread":0.275490664211895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011409049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9465773,0.020916317,0.028041817,0.0022964412,0.000788194,0.0010197677,0.000114584356,0.000010119176,0.00023547588],"genre_scores_gemma":[0.9969554,0.0018416841,0.0001591631,0.00028401642,0.00030402953,0.00012559029,0.0000109171515,0.000012259849,0.00030696145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931806,0.000016281037,0.00023165334,0.0001431291,0.000104972525,0.00018591082],"domain_scores_gemma":[0.9994811,0.000086771535,0.00014343025,0.00018357538,0.00009261114,0.0000125280085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029874843,0.0000883389,0.00009574381,0.0000131623465,0.00013378442,0.000024075794,0.00018508169,0.00005424131,0.00000402241],"category_scores_gemma":[0.000021128164,0.00005748579,0.00007585989,0.000075839336,0.00007637373,0.000008087414,0.00004580065,0.00004835837,2.4631692e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007605497,0.000030937692,0.000083682884,0.00002009785,0.000014062529,3.388396e-8,0.00017376381,0.00045628136,0.99176,0.0012647096,0.0020323177,0.004088059],"study_design_scores_gemma":[0.00081406476,0.000066733795,0.00011374336,0.00005247152,0.000015540869,4.774758e-7,0.00030026748,0.0023688998,0.92662585,0.00013859553,0.06941495,0.00008841494],"about_ca_topic_score_codex":0.00044016883,"about_ca_topic_score_gemma":0.0004207649,"teacher_disagreement_score":0.06738263,"about_ca_system_score_codex":0.000020640098,"about_ca_system_score_gemma":0.00007429219,"threshold_uncertainty_score":0.23442024},"labels":[],"label_agreement":null},{"id":"W2011446012","doi":"10.1097/cad.0b013e3280115fe8","title":"Type II combi-molecules: design and binary targeting properties of the novel triazolinium-containing molecules JDD36 and JDE05","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Royal Victoria Regional Health Centre; Health Canada; Royal Victoria Hospital","funders":"","keywords":"Epidermal growth factor receptor; Epidermal growth factor; Tyrosine kinase; Biology; Growth factor receptor; Molecular biology; DU145; Comet assay; Receptor; A431 cells; LNCaP; DNA damage; Chemistry; Cancer research; Cell biology; Biochemistry; Cancer cell; Cell; DNA; Cancer; Cell cycle","score_opus":0.018886906288876265,"score_gpt":0.2368112892721645,"score_spread":0.21792438298328823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011446012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895168,0.009137196,0.0005708647,0.00020760564,0.00015213684,0.00019688685,0.000011639379,0.000008606222,0.00019827396],"genre_scores_gemma":[0.9976277,0.0011283075,0.00054866384,0.00025036474,0.00011639191,0.000016140533,0.000013152544,0.000020934829,0.00027835649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990793,0.000055782166,0.000246888,0.00030327067,0.00010557733,0.00020917186],"domain_scores_gemma":[0.999508,0.000014232775,0.00013399625,0.0001946059,0.000118235694,0.00003089789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017270102,0.00016923292,0.00019713855,0.00003236125,0.00016943982,0.00002609824,0.00016466387,0.00010552683,0.000004935971],"category_scores_gemma":[0.000036865138,0.00012303187,0.000056113164,0.00008789395,0.00020106928,0.000009284967,0.00021769281,0.00008739141,6.875916e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001759955,0.00005083661,0.002087145,0.0000368236,0.00004555577,6.204264e-7,0.00023344997,0.00037287065,0.99563664,0.000045879468,0.00075488345,0.00055931683],"study_design_scores_gemma":[0.0008000873,0.00034652711,0.0018825318,0.00010811126,0.000042255753,0.000005533646,0.00044121826,0.000902041,0.99369735,0.000026047668,0.0015370427,0.00021125357],"about_ca_topic_score_codex":0.00031436543,"about_ca_topic_score_gemma":0.000012116796,"teacher_disagreement_score":0.008110897,"about_ca_system_score_codex":0.0000067217647,"about_ca_system_score_gemma":0.00009148256,"threshold_uncertainty_score":0.5017094},"labels":[],"label_agreement":null},{"id":"W2017047836","doi":"10.1097/00001813-200511000-00002","title":"Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer","year":2005,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Prostate cancer; Medicine; Prostate; In vivo; Cancer; Malignancy; Cancer research; Internal medicine; Endocrinology; Pathology; Biology","score_opus":0.04893492827377968,"score_gpt":0.3765215155615032,"score_spread":0.3275865872877235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017047836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012969878,0.9715702,0.0000049148425,0.00081129564,0.00032681212,0.011580391,0.0021223968,0.000103356295,0.0005107613],"genre_scores_gemma":[0.0062205726,0.913175,0.00007825874,0.00016321629,0.0008720589,0.0077936356,0.000517908,0.00025240678,0.07092695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953743,0.00019387767,0.0011480304,0.0011792867,0.0008914337,0.0012130461],"domain_scores_gemma":[0.99752975,0.00010467674,0.000764686,0.00060145615,0.0006314853,0.00036794218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004734424,0.0010410356,0.0029516355,0.00045259154,0.00025871623,0.000094904746,0.00035187308,0.00048355895,0.00035543242],"category_scores_gemma":[0.000028867906,0.00076180545,0.0007340525,0.00045069895,0.00048313502,0.0003124439,0.00018931832,0.0007401257,0.000028318853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010266289,0.00027717938,0.00015296708,0.073513515,0.0024301503,0.000043774864,0.001855743,0.0000042143056,0.0010008658,0.0001511166,0.0007163727,0.9188275],"study_design_scores_gemma":[0.0054456564,0.00095971645,0.000090770496,0.027285356,0.0034186142,0.000042755913,0.00040718168,0.00009451016,0.0047629494,0.00013788458,0.95632654,0.0010280428],"about_ca_topic_score_codex":0.00071580656,"about_ca_topic_score_gemma":0.000049594073,"teacher_disagreement_score":0.9556102,"about_ca_system_score_codex":0.0006598404,"about_ca_system_score_gemma":0.0034987722,"threshold_uncertainty_score":0.9994833},"labels":[],"label_agreement":null},{"id":"W2017218408","doi":"10.1097/cad.0b013e328011fd99","title":"An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Capecitabine; Medicine; Neutropenia; Tolerability; Internal medicine; Chemotherapy; Gastroenterology; Cisplatin; Transplantation; Refractory (planetary science); Germ cell tumors; Surgery; Progressive disease; Multicenter trial; Oncology; Adverse effect; Cancer; Randomized controlled trial; Multicenter study","score_opus":0.01958008612328598,"score_gpt":0.3350720642321228,"score_spread":0.31549197810883683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017218408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719983,0.00014307485,0.000010492446,0.000034887013,0.00017419044,0.0018369628,0.00012002074,0.000025622388,0.00045491714],"genre_scores_gemma":[0.99826014,0.00003436452,0.00063550845,0.00019753294,0.00008532514,0.000048671132,0.00021075433,0.000048644353,0.0004790694],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982668,0.000040108014,0.00051054376,0.00040217608,0.00041612596,0.0003642218],"domain_scores_gemma":[0.99875003,0.00006448511,0.00032995746,0.00044789596,0.0001527744,0.0002548855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001690929,0.00024737074,0.0005279326,0.00014024449,0.000071397466,0.0000169517,0.00017508991,0.00007064408,0.00032103912],"category_scores_gemma":[0.000039204762,0.00016770116,0.000042081363,0.00027891182,0.00007484571,0.0002588621,0.00006658258,0.00014796745,0.000008462564],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.339884,0.104505084,0.498621,0.00020639549,0.00027851533,0.0003361254,0.0010704917,0.000006822506,0.004620655,0.000007302133,0.0002514253,0.050212182],"study_design_scores_gemma":[0.6320537,0.022568239,0.3383034,0.0003848978,0.0003974662,9.008917e-7,0.00016527642,0.00009758169,0.0052384213,0.0000019253262,0.0005066061,0.00028162295],"about_ca_topic_score_codex":0.00065886276,"about_ca_topic_score_gemma":0.00011554874,"teacher_disagreement_score":0.29216966,"about_ca_system_score_codex":0.00012934413,"about_ca_system_score_gemma":0.00024671707,"threshold_uncertainty_score":0.6838655},"labels":[],"label_agreement":null},{"id":"W2030330520","doi":"10.1097/01.cad.0000132231.28888.fa","title":"2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Cytotoxicity; Intracellular; P-glycoprotein; Multiple drug resistance; Verapamil; Pharmacology; Doxorubicin; Cell culture; K562 cells; Cytotoxic T cell; Chemistry; Biology; Biochemistry; Cell; In vitro; Chemotherapy; Calcium; Antibiotics","score_opus":0.01199001358614045,"score_gpt":0.26484568961881144,"score_spread":0.252855676032671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030330520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823806,0.005638316,0.00046857313,0.0047995998,0.00058431254,0.000759518,0.000059824146,0.00023423575,0.0050749867],"genre_scores_gemma":[0.9758782,0.0040060543,0.0014277712,0.0009011613,0.00038420243,0.000074211326,0.000037255722,0.00007825156,0.017212903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773127,0.000018476452,0.0004635119,0.00062569045,0.0005200643,0.0006410013],"domain_scores_gemma":[0.9989404,0.000032676096,0.00015114092,0.00039347043,0.00017175986,0.0003105405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023713813,0.00037858164,0.0006803723,0.00014123174,0.0002325703,0.00003400968,0.00016149326,0.00017938783,0.00015467],"category_scores_gemma":[0.000019665664,0.000317099,0.00018210012,0.0003431222,0.00015066935,0.0002480358,0.000034432185,0.00034560927,0.000068838905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002606925,0.00094702624,0.009911261,0.0023378409,0.0007605251,0.0006266527,0.00897957,0.00007325242,0.9427873,0.0249949,0.0027841758,0.0031905703],"study_design_scores_gemma":[0.026267365,0.00022295752,0.035453495,0.0022023814,0.0006949563,0.000050255527,0.0012826625,0.00011702058,0.8579681,0.0028146445,0.07152954,0.0013966172],"about_ca_topic_score_codex":0.00013682358,"about_ca_topic_score_gemma":0.0004201867,"teacher_disagreement_score":0.0848192,"about_ca_system_score_codex":0.00017806617,"about_ca_system_score_gemma":0.00023099306,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W2031185392","doi":"10.1097/00001813-200211002-00004","title":"Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkinʼs lymphoma","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Watchful waiting; Rituximab; Chemotherapy; Autologous stem-cell transplantation; Lymphoma; Oncology; Aggressive lymphoma; Non-Hodgkin's lymphoma; Disease; Internal medicine; Clinical trial; Surgery; Intensive care medicine; Cancer","score_opus":0.07813416068665378,"score_gpt":0.3619001896838279,"score_spread":0.2837660289971741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031185392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025294744,0.9886997,0.0000116445735,0.001359663,0.00019862755,0.0056976257,0.0006277902,0.000017928009,0.00085755443],"genre_scores_gemma":[0.0022440895,0.98855525,0.00023575875,0.00031702942,0.00013475883,0.0068909205,0.00009490042,0.0000565547,0.0014707404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821234,0.00008612999,0.00053428515,0.00052635133,0.0002940745,0.00034682572],"domain_scores_gemma":[0.997489,0.0009192613,0.0007384885,0.00065798016,0.00010365454,0.00009164885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014553797,0.0005749176,0.0014482113,0.00009626942,0.0002753781,0.000039907958,0.00019874795,0.00013635341,0.0000925549],"category_scores_gemma":[0.00001005408,0.00025347777,0.0006469331,0.00021976049,0.00024385675,0.000032318778,0.00009353371,0.00007770297,0.000024880734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006350499,0.0008592931,0.00005179738,0.0029327718,0.0056571416,0.00007025359,0.00052613864,0.0000065881773,1.0180247e-7,0.0010363612,0.0027817718,0.98601425],"study_design_scores_gemma":[0.0052480255,0.00093753205,0.0009504561,0.026555391,0.010714503,0.000052856118,0.0005064697,0.00015612137,0.00011671836,0.000010339838,0.95442116,0.00033044117],"about_ca_topic_score_codex":0.00019558214,"about_ca_topic_score_gemma":0.000006564529,"teacher_disagreement_score":0.98568386,"about_ca_system_score_codex":0.00054700975,"about_ca_system_score_gemma":0.0001951002,"threshold_uncertainty_score":0.9999918},"labels":[],"label_agreement":null},{"id":"W2032041633","doi":"10.1097/cad.0b013e32836009d7","title":"Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells","year":2013,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Pancreatic cancer; Apoptosis; Cell growth; Cancer research; Reactive oxygen species; Gemcitabine; Senescence; Intracellular; Cell cycle; Cell culture; Epithelial–mesenchymal transition; Cancer; Cancer cell; Chemistry; Biology; Cell biology; Biochemistry; Metastasis","score_opus":0.006478644655596788,"score_gpt":0.23630804437407688,"score_spread":0.2298293997184801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032041633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970679,0.002070329,0.000024289086,0.00020546744,0.00006633095,0.00046107886,0.000040610914,0.00000223589,0.000061715415],"genre_scores_gemma":[0.9990341,0.0005998695,0.0000066760404,0.00011257444,0.000036757796,0.00014040912,0.0000065185186,0.000011941792,0.00005114825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906474,0.00019598658,0.00024896913,0.00020057845,0.00017309275,0.00011661172],"domain_scores_gemma":[0.999156,0.0000733314,0.00024627248,0.0003410727,0.00016367409,0.00001965804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002180522,0.00013641878,0.00035466757,0.000049575574,0.000049482365,0.00000598002,0.00014636424,0.00006638656,0.000011727518],"category_scores_gemma":[0.00005108157,0.000076995646,0.00014537844,0.00027533388,0.00021151967,0.0000036104468,0.00008872961,0.000053663072,4.3479855e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029203859,0.000022265684,0.0273697,0.00016622011,0.0008697967,8.559488e-8,0.0002441429,0.0015170054,0.9693337,0.000016856508,0.000086057975,0.00034493647],"study_design_scores_gemma":[0.00029235534,0.00027624043,0.006212338,0.00011322111,0.00051620556,8.8345935e-8,0.00008154891,0.00020235474,0.9921771,0.0000033411775,0.000047512087,0.000077673205],"about_ca_topic_score_codex":0.00041842845,"about_ca_topic_score_gemma":0.00005348813,"teacher_disagreement_score":0.022843393,"about_ca_system_score_codex":0.000010355543,"about_ca_system_score_gemma":0.000058272417,"threshold_uncertainty_score":0.31397915},"labels":[],"label_agreement":null},{"id":"W2036467698","doi":"10.1097/cad.0b013e32835006f5","title":"A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Protopanaxadiol; Pharmacokinetics; Pharmacology; Oral administration; Cmax; Prostate cancer; Aglycone; Chemistry; Ginsenoside; Cancer; Medicine; Internal medicine; Stereochemistry; Ginseng; Glycoside","score_opus":0.024887690822894378,"score_gpt":0.28923429671459977,"score_spread":0.2643466058917054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036467698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995803,0.0006473704,0.0015076494,0.0002811711,0.00004698433,0.0012348831,0.0003122188,0.000010148265,0.00015656395],"genre_scores_gemma":[0.9983006,0.0005565381,0.00019716757,0.0002930982,0.00009712502,0.00037011493,0.000028219727,0.000018962717,0.00013815613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999061,0.000058251637,0.00020956672,0.00024558167,0.00013988344,0.0002857376],"domain_scores_gemma":[0.9992037,0.000019792793,0.00027284416,0.00031590875,0.00013040722,0.000057349174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017629347,0.00017638467,0.00024001251,0.000023043161,0.00009328215,0.0000069844414,0.00014453972,0.00012543435,0.0000023922364],"category_scores_gemma":[0.000017115173,0.000115768344,0.00013455018,0.0001504584,0.00014723839,0.000015055751,0.00009656647,0.00010915788,6.500475e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121395846,0.00021046684,0.0045122337,0.00003651685,0.00007840029,3.2293542e-8,0.00028533436,0.0014424559,0.9850585,0.0001671817,0.000043069056,0.008044417],"study_design_scores_gemma":[0.0007161818,0.000077616074,0.047350448,0.000037719547,0.000044884924,7.35933e-7,0.000036700552,0.0049525066,0.94613457,0.00002887294,0.00045237536,0.00016738934],"about_ca_topic_score_codex":0.00032959046,"about_ca_topic_score_gemma":0.00004769414,"teacher_disagreement_score":0.042838212,"about_ca_system_score_codex":0.000026866855,"about_ca_system_score_gemma":0.00011085651,"threshold_uncertainty_score":0.47208962},"labels":[],"label_agreement":null},{"id":"W2041352031","doi":"10.1097/00001813-200501000-00014","title":"The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Daunorubicin; Doxorubicin; Anthracycline; Pharmacology; Chemistry; Reactive oxygen species; Biochemistry; Biology; Leukemia; Medicine; Chemotherapy; Internal medicine","score_opus":0.014207030151936237,"score_gpt":0.2608693665313333,"score_spread":0.24666233637939705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041352031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98323715,0.0012213269,0.00018755226,0.010646424,0.00017315726,0.0007126006,0.000049027334,0.00004123743,0.0037314997],"genre_scores_gemma":[0.9866558,0.011375963,0.000102623766,0.0011695068,0.0003231116,0.00003150704,0.000045990048,0.000027012997,0.00026853487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857944,0.000056057987,0.0004205082,0.00026265878,0.00040166068,0.00027968758],"domain_scores_gemma":[0.9988803,0.0002134216,0.00031645934,0.0003279758,0.0002089747,0.000052825224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003111391,0.00021730433,0.00037112203,0.000055829256,0.00034509844,0.000050218718,0.00013278083,0.00010529869,0.000012204873],"category_scores_gemma":[0.000072095885,0.00012969645,0.00012432765,0.00032763428,0.0004289198,0.00041678268,0.000047820566,0.0002684313,0.000008154895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020602201,0.000099574136,0.00059584226,0.00015780321,0.000060467417,0.0000032670105,0.008576943,0.000026981867,0.9873328,0.0011903823,0.0005091526,0.0012407639],"study_design_scores_gemma":[0.0025441467,0.000107665735,0.009583054,0.00022866328,0.00010494068,0.000016930615,0.005602867,0.000031545984,0.97820264,0.00057821994,0.002846086,0.00015320962],"about_ca_topic_score_codex":0.0007281744,"about_ca_topic_score_gemma":0.00007045106,"teacher_disagreement_score":0.010154636,"about_ca_system_score_codex":0.00011254551,"about_ca_system_score_gemma":0.00012318064,"threshold_uncertainty_score":0.5288868},"labels":[],"label_agreement":null},{"id":"W2055722183","doi":"10.1097/00001813-200503000-00009","title":"Enhancement of antineoplastic action of 5-aza-2???-deoxycytidine by zebularine on L1210 leukemia","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Deoxycytidine; Cancer research; Decitabine; In vivo; Leukemia; L1210 cells; DNA methylation; Biology; Molecular biology; Chemistry; In vitro; Cytotoxicity; Gene; Immunology; Cancer; Gene expression; Biochemistry; Gemcitabine; Genetics","score_opus":0.011030437415811993,"score_gpt":0.2846017155389284,"score_spread":0.2735712781231164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055722183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511695,0.0014975471,0.0020055084,0.000168627,0.00015537544,0.00013649947,0.00004107372,0.0000057627344,0.0008726483],"genre_scores_gemma":[0.99432117,0.0037979353,0.00037014266,0.000073704825,0.00028063546,0.0000133335625,0.00013424695,0.000019985333,0.0009888342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989793,0.00002935424,0.00033445508,0.00027600088,0.00020159491,0.00017934352],"domain_scores_gemma":[0.9993076,0.000015990603,0.00024192443,0.00027376582,0.00011498701,0.00004574345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001394779,0.00014893648,0.00021191782,0.000051501003,0.000034228335,0.0000055738665,0.00011712405,0.00011114732,0.00008406624],"category_scores_gemma":[0.00002533413,0.00014439307,0.00008134648,0.000101560596,0.00005644892,0.000005353076,0.00004816406,0.000070225025,0.000007243524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086137945,0.00012177937,0.0020187385,0.000046243284,0.000053081647,9.3413206e-8,0.000035830595,0.00090915774,0.98172706,0.000026686963,0.001183919,0.013791273],"study_design_scores_gemma":[0.0006832309,0.0003189654,0.0019375011,0.000036483627,0.00002648607,1.9468101e-7,0.000017809822,0.00028104626,0.9680893,0.0000114720415,0.028458256,0.0001392641],"about_ca_topic_score_codex":0.00011307848,"about_ca_topic_score_gemma":0.000022067486,"teacher_disagreement_score":0.027274337,"about_ca_system_score_codex":0.0000380288,"about_ca_system_score_gemma":0.000083936335,"threshold_uncertainty_score":0.58881783},"labels":[],"label_agreement":null},{"id":"W2057651711","doi":"10.1097/cad.0b013e328350e835","title":"Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Doxorubicin; Cisplatin; Osteosarcoma; Methotrexate; Apoptosis; Cancer research; Chemotherapy; Pharmacology; Combination therapy; Medicine; Cytotoxic T cell; Chemistry; Immunology; In vitro; Internal medicine; Biochemistry","score_opus":0.010772700577210914,"score_gpt":0.25216623206455535,"score_spread":0.24139353148734444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057651711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978545,0.0008415877,0.00004022924,0.0002234165,0.00024553132,0.00037857177,0.00014789715,0.000022203028,0.00024609294],"genre_scores_gemma":[0.9982424,0.00044919827,0.00042070018,0.0004989644,0.00020978194,0.00002864768,0.000037103917,0.00006178652,0.000051460112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979341,0.0001233998,0.0004355266,0.00060726795,0.0003096093,0.0005900862],"domain_scores_gemma":[0.9990585,0.000048309463,0.0002384865,0.00035839924,0.0000896172,0.00020670427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043746832,0.0003401251,0.0004689841,0.00012128089,0.00007792159,0.000033581764,0.00017202809,0.00026717474,0.000039938714],"category_scores_gemma":[0.000043077172,0.00035605518,0.00009192635,0.00022803723,0.00015297715,0.000043127617,0.00023873706,0.0002098712,0.000015690055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087223736,0.00019644316,0.002868353,0.0000716626,0.0000525666,4.3375906e-7,0.0017124595,0.000008283176,0.9915667,0.000010028219,0.00017597627,0.0032498576],"study_design_scores_gemma":[0.0008343903,0.00011507759,0.0018330369,0.00010525205,0.000025818657,0.0000012822622,0.0007734439,0.000012125297,0.9954233,0.000006079077,0.0004531693,0.00041700003],"about_ca_topic_score_codex":0.0005742535,"about_ca_topic_score_gemma":0.00003390459,"teacher_disagreement_score":0.0038566124,"about_ca_system_score_codex":0.00007577865,"about_ca_system_score_gemma":0.00007738233,"threshold_uncertainty_score":0.99988914},"labels":[],"label_agreement":null},{"id":"W2058098342","doi":"10.1097/00001813-200210000-00004","title":"Epirubicin/docetaxel regimen in progressive breast cancer—a phase II study","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Docetaxel; Epirubicin; Medicine; Regimen; Neutropenia; Metastatic breast cancer; Febrile neutropenia; Internal medicine; Breast cancer; Chemotherapy; Adverse effect; Phases of clinical research; Oncology; Surgery; Gastroenterology; Cancer","score_opus":0.03439308193999131,"score_gpt":0.38094733083647836,"score_spread":0.34655424889648706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058098342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758689,0.009134832,5.203664e-7,0.009139092,0.00050018827,0.001720604,0.00012468513,0.000100646765,0.0034105526],"genre_scores_gemma":[0.9839664,0.0029129717,0.000018619281,0.0015644802,0.0007362084,0.0009263031,0.000018839984,0.000050500763,0.00980566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794525,0.00008068509,0.0004130727,0.0006138284,0.0003427158,0.00060446793],"domain_scores_gemma":[0.99907887,0.00003765973,0.0001895787,0.00036601757,0.00011896167,0.00020890469],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013299346,0.00034294734,0.0006970262,0.00022894278,0.00016835314,0.000019472005,0.00016863695,0.00009967555,0.0076357964],"category_scores_gemma":[0.0000052139408,0.0002921809,0.00012208556,0.00060613116,0.00013024495,0.00017942087,0.00008853129,0.00033562418,0.00008145901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026227792,0.03549938,0.52552396,0.00024747825,0.0017054356,0.0014032867,0.026676293,0.000038739374,0.009467698,0.00003687029,0.097905435,0.29887265],"study_design_scores_gemma":[0.32476437,0.022051398,0.42145255,0.002364264,0.0060759606,0.00059329707,0.010285923,0.0040542944,0.044578206,0.000106772866,0.16009293,0.0035800138],"about_ca_topic_score_codex":0.0031200505,"about_ca_topic_score_gemma":0.00040733116,"teacher_disagreement_score":0.32214162,"about_ca_system_score_codex":0.0004120816,"about_ca_system_score_gemma":0.00015295074,"threshold_uncertainty_score":0.99995303},"labels":[],"label_agreement":null},{"id":"W2058595915","doi":"10.1097/00001813-200112004-00003","title":"Maximizing the response to Herceptin® therapy through optimal use and patient selection","year":2001,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Immunohistochemistry; Medicine; Concordance; Oncology; Breast cancer; Trastuzumab; Metastatic breast cancer; Internal medicine; Targeted therapy; Cancer; Disease; Fluorescence in situ hybridization; Gene; Biology","score_opus":0.17277203939993846,"score_gpt":0.44606148375622434,"score_spread":0.2732894443562859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058595915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018827736,0.97485393,0.00004529744,0.002119873,0.00034444523,0.0032484864,0.000054685675,0.00010353307,0.00040200018],"genre_scores_gemma":[0.000341002,0.9930012,0.00086080644,0.001901197,0.00055168546,0.00088090764,0.000018673585,0.00018130666,0.0022631781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604666,0.00078148127,0.0006679043,0.00088380487,0.00083940517,0.0007807594],"domain_scores_gemma":[0.99788344,0.0005897749,0.00024281903,0.00077235437,0.0002689068,0.00024271877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084203365,0.0005864025,0.0014822666,0.00023779151,0.0003068845,0.00021395306,0.00030673674,0.0003411278,0.00061198225],"category_scores_gemma":[0.00018755729,0.00037411178,0.00035696282,0.0012951435,0.00018261511,0.00019780039,0.00019348807,0.0011203927,0.00012817416],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066453754,0.00008119849,0.00014462585,0.0014293543,0.0002608382,0.000029935916,0.002177771,0.000008980207,0.000055488515,0.000005423769,0.011977856,0.983164],"study_design_scores_gemma":[0.0006280463,0.0005447843,0.00017830648,0.007664186,0.00023151725,0.00014388742,0.0002749382,0.000010918971,0.000091588015,0.0000023589926,0.9898449,0.00038452266],"about_ca_topic_score_codex":0.0013295313,"about_ca_topic_score_gemma":0.000026023494,"teacher_disagreement_score":0.98277944,"about_ca_system_score_codex":0.0007511907,"about_ca_system_score_gemma":0.0010542162,"threshold_uncertainty_score":0.9998711},"labels":[],"label_agreement":null},{"id":"W2062087170","doi":"10.1097/00001813-200411000-00003","title":"Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Efflux; P-glycoprotein; Paclitaxel; Peptide; Solubility; Glycoprotein; Chemistry; Vector (molecular biology); Biophysics; Pharmacology; Biochemistry; Internal medicine; Biology; Medicine; Organic chemistry; Multiple drug resistance; Chemotherapy","score_opus":0.01104076863687449,"score_gpt":0.27050389775520434,"score_spread":0.25946312911832986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062087170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290556,0.0028785826,0.00041471107,0.001918191,0.00012003789,0.00061618205,0.00008098581,0.00006482196,0.0010009394],"genre_scores_gemma":[0.9957045,0.0020005174,0.0007603118,0.00021281265,0.00011197085,0.000050605333,0.000027048527,0.00003254061,0.0010997357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982734,0.000023414936,0.0004624207,0.0005165564,0.00035055145,0.0003736577],"domain_scores_gemma":[0.999231,0.000047429006,0.00014018503,0.0002853958,0.000102297316,0.00019373643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031107967,0.00028181588,0.00066686724,0.00008298423,0.00009996759,0.000014444983,0.000088652385,0.00014501062,0.00013069175],"category_scores_gemma":[0.000013583785,0.00022904614,0.000119114724,0.00020303753,0.00039108,0.00018056245,0.000012652596,0.00020613987,0.000002639984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088143384,0.00087059056,0.12681821,0.004259021,0.00046262622,0.000087975306,0.0044946834,0.000036755613,0.84299815,0.0053218766,0.00018667139,0.013582031],"study_design_scores_gemma":[0.004535744,0.0005243833,0.39200985,0.0008483189,0.00023347978,0.000015155119,0.0013797631,0.000008501561,0.59668154,0.0019074145,0.0014408716,0.00041494632],"about_ca_topic_score_codex":0.0011044379,"about_ca_topic_score_gemma":0.0007039455,"teacher_disagreement_score":0.26519164,"about_ca_system_score_codex":0.000041102172,"about_ca_system_score_gemma":0.0002725336,"threshold_uncertainty_score":0.9340231},"labels":[],"label_agreement":null},{"id":"W2062392807","doi":"10.1097/cad.0b013e32835a56bc","title":"Peg-filgrastim and cabazitaxel in prostate cancer patients","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Cabazitaxel; Febrile neutropenia; Medicine; Neutropenia; Filgrastim; Internal medicine; Prostate cancer; Docetaxel; Surgery; Oncology; Cancer; Chemotherapy","score_opus":0.011565426539610167,"score_gpt":0.29568560696011625,"score_spread":0.2841201804205061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062392807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991612,0.002599025,0.0000018043856,0.0009081812,0.0006660748,0.00048407016,0.000061017032,0.000041571453,0.003626245],"genre_scores_gemma":[0.9930688,0.0029231643,0.000030977168,0.0009022216,0.0003083135,0.0002871512,0.000017336652,0.000031840857,0.002430174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988584,0.000023910987,0.0002167695,0.0002469384,0.00020044115,0.0004535697],"domain_scores_gemma":[0.9994679,0.00001935913,0.00007195382,0.00015923611,0.000087453394,0.00019407304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008967007,0.00017059388,0.0002831759,0.000117312666,0.00008647053,0.00001860268,0.00004666225,0.000052152736,0.00037103536],"category_scores_gemma":[0.000010196645,0.0001470265,0.000048522183,0.00028129955,0.000079778045,0.00026395204,0.000046534242,0.00021624102,0.000041150295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006445954,0.00024185091,0.9807564,0.000087992536,0.000038775917,0.0000021271364,0.0013691637,0.000004786204,0.001554973,0.00005464288,0.0033626168,0.012462182],"study_design_scores_gemma":[0.0026695929,0.000083930754,0.95334005,0.00018614324,0.0000902205,0.000005305123,0.000188746,0.000013110539,0.00502586,0.000015878946,0.038171615,0.00020951714],"about_ca_topic_score_codex":0.003055501,"about_ca_topic_score_gemma":0.00036400775,"teacher_disagreement_score":0.034808997,"about_ca_system_score_codex":0.00015958653,"about_ca_system_score_gemma":0.00011481372,"threshold_uncertainty_score":0.5995566},"labels":[],"label_agreement":null},{"id":"W2062686953","doi":"10.1097/00001813-200504000-00009","title":"In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Doxorubicin; Toxicity; Mitomycin C; Microsphere; In vivo; Therapeutic index; Pharmacology; Chemotherapy; Medicine; Dextran; Chemistry; Surgery; Drug; Internal medicine; Biology; Chromatography","score_opus":0.01139503563033102,"score_gpt":0.2569178602094529,"score_spread":0.2455228245791219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062686953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984618,0.00063153147,0.00008431559,0.00033012443,0.00005307316,0.00033354113,0.00003750822,0.000023379016,0.000044718377],"genre_scores_gemma":[0.9976313,0.00009513178,0.002024044,0.0001450024,0.00003451017,0.000008112924,0.0000014933821,0.000014973022,0.000045439607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989247,0.000054185843,0.00030086312,0.00028817134,0.0001842082,0.00024791443],"domain_scores_gemma":[0.99944603,0.00007336937,0.00015382233,0.00013740672,0.0001239954,0.00006537765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020060867,0.00014437223,0.00024593974,0.00007074094,0.00009104149,0.00004912885,0.00009194355,0.000052464948,0.00011726472],"category_scores_gemma":[0.000015418771,0.00013265213,0.000014986955,0.00026157635,0.00010755822,0.00068114937,0.000055247066,0.00007191705,0.000004327066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011363076,0.00015939209,0.0043924814,0.000046729074,0.000006079923,0.000002413072,0.000810214,0.0026628259,0.9911673,0.00022031034,0.000045346675,0.00037326646],"study_design_scores_gemma":[0.0025341373,0.00007370304,0.0066172495,0.00013712283,0.00002708682,0.0000051795164,0.00008866511,0.014516695,0.9757644,0.000037198148,0.00003140892,0.00016716069],"about_ca_topic_score_codex":0.00061792845,"about_ca_topic_score_gemma":0.0004998869,"teacher_disagreement_score":0.015402918,"about_ca_system_score_codex":0.000084376894,"about_ca_system_score_gemma":0.00008944105,"threshold_uncertainty_score":0.5409397},"labels":[],"label_agreement":null},{"id":"W2064652673","doi":"10.1097/cad.0b013e32831c14ec","title":"Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Doxycycline; Cancer research; Internal medicine; Adenocarcinoma; Human breast; Medicine; Oncology; Breast cancer; Biology; Antibiotics; Cancer; Microbiology","score_opus":0.015914708741084173,"score_gpt":0.2997624907008337,"score_spread":0.2838477819597495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064652673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972015,0.00068315346,0.00035539962,0.00043345185,0.0001409797,0.00021477179,0.0000507621,0.000010789764,0.0009092001],"genre_scores_gemma":[0.99678147,0.0006060591,0.00013105026,0.0011494693,0.00017620882,0.000018430714,0.000047718004,0.000028693701,0.0010608804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894094,0.000025784457,0.00026278128,0.00035387854,0.00014181953,0.00027479808],"domain_scores_gemma":[0.99937,0.000004150283,0.00014285538,0.00035030462,0.00006959,0.000063117805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007907888,0.00019482475,0.00023908068,0.00008294867,0.00005203797,0.000016474427,0.00020246902,0.00008603882,0.00012650024],"category_scores_gemma":[6.265072e-7,0.00017880027,0.00008868857,0.00016406499,0.000057577214,0.000008249827,0.00003190446,0.000121385274,0.0000033968172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001350945,0.00024181124,0.0018532607,0.000017817252,0.00008104164,0.0000018903747,0.00023253418,0.00007987082,0.98714465,0.00010037882,0.00015213797,0.009959542],"study_design_scores_gemma":[0.0016014039,0.00033922622,0.016555233,0.00007902266,0.00004672973,0.000012642166,0.00016170013,0.00007223663,0.974087,0.000102099235,0.006683369,0.00025934065],"about_ca_topic_score_codex":0.000273537,"about_ca_topic_score_gemma":0.0002160402,"teacher_disagreement_score":0.014701973,"about_ca_system_score_codex":0.000037425925,"about_ca_system_score_gemma":0.00007255561,"threshold_uncertainty_score":0.72912633},"labels":[],"label_agreement":null},{"id":"W2069327639","doi":"10.1097/cad.0b013e328327994e","title":"Tranilast inhibits the growth and metastasis of mammary carcinoma","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Tranilast; Mammary carcinoma; Metastasis; Carcinoma; Cancer research; Internal medicine; Medicine; Oncology; Cancer","score_opus":0.0076221064644514626,"score_gpt":0.2393057148340062,"score_spread":0.23168360836955473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069327639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140096,0.0071680187,0.0001229718,0.00056715915,0.00004114599,0.000101193255,0.000035095632,0.00000883825,0.00055459334],"genre_scores_gemma":[0.9983999,0.0005931871,0.00015863356,0.0006232136,0.00010413687,0.000008372291,0.000018656461,0.000010591777,0.00008331499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993101,0.000039043465,0.00015343804,0.00022947222,0.00011109802,0.00015689452],"domain_scores_gemma":[0.99958,0.000011199815,0.00006885937,0.00024020097,0.000049370836,0.0000503297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006338078,0.00012011262,0.00013606524,0.00002450857,0.00006299741,0.000016187381,0.00018374524,0.000053185136,0.00000910731],"category_scores_gemma":[0.000015702177,0.00009050534,0.00007158448,0.00008081933,0.00009243147,0.000005659804,0.000048829967,0.00004991581,9.360889e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048076927,0.00007403569,0.0065975557,0.00004648769,0.00007375789,0.0000016165537,0.0002515307,0.000009293376,0.98074365,0.00024401072,0.001146531,0.010763487],"study_design_scores_gemma":[0.0003640213,0.000086390755,0.04200055,0.000015768483,0.000046974736,0.000003201965,0.00006081081,0.0000074807617,0.95542425,0.000073844596,0.0017980074,0.000118705706],"about_ca_topic_score_codex":0.000035794055,"about_ca_topic_score_gemma":0.0000054562474,"teacher_disagreement_score":0.035402995,"about_ca_system_score_codex":0.0000034177833,"about_ca_system_score_gemma":0.00007121525,"threshold_uncertainty_score":0.36907005},"labels":[],"label_agreement":null},{"id":"W2069340479","doi":"10.1097/cad.0b013e3280262427","title":"Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells","year":2007,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Gene expression profiling; Biology; Vinca; Gene; Gene expression; Topoisomerase; Computational biology; Drug; Microarray; Microarray analysis techniques; Cancer research; Pharmacology; Genetics; DNA","score_opus":0.03234895651611599,"score_gpt":0.3474229593625183,"score_spread":0.31507400284640236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069340479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019172756,0.97755134,0.00035205125,0.00010322031,0.0004793395,0.001912299,0.0002935081,0.00001633349,0.00011915407],"genre_scores_gemma":[0.009725203,0.9865681,0.0001820414,0.000092646274,0.00038635076,0.0008174085,0.00035490195,0.00007794253,0.0017954079],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795586,0.00022882072,0.0006717834,0.0006165355,0.00023616856,0.00029084642],"domain_scores_gemma":[0.99851936,0.000085846754,0.0006036483,0.0006221117,0.00010931074,0.00005970209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008321556,0.00035053442,0.0005937663,0.00019857152,0.00012607677,0.00002196106,0.00046469073,0.00036551387,0.00003929637],"category_scores_gemma":[0.000026258534,0.0002479056,0.00038339838,0.00027482765,0.00012024547,0.000006310902,0.00007590461,0.0001656294,0.0000026878824],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004514308,0.00008363638,0.0000179289,0.0013170096,0.000104264516,2.8408328e-7,0.000121397126,0.000006257127,0.8253995,0.000003290034,0.011364612,0.16113035],"study_design_scores_gemma":[0.0004209223,0.00005641683,0.000046699475,0.0011457189,0.0000582675,7.8184314e-7,0.00009307885,0.0000032346438,0.49531895,0.0000038207295,0.50271314,0.0001389804],"about_ca_topic_score_codex":0.000049507187,"about_ca_topic_score_gemma":0.000004836773,"teacher_disagreement_score":0.49134853,"about_ca_system_score_codex":0.00007249609,"about_ca_system_score_gemma":0.00039217187,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W2073605475","doi":"10.1097/cad.0b013e32832ae55f","title":"The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Marine Sponges and Natural Products","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Apoptosis; Annexin; Caspase; Programmed cell death; Cancer cell; Cell biology; Biology; Cancer research; Chemistry; Cancer; Biochemistry","score_opus":0.005415570056929603,"score_gpt":0.23955643825708597,"score_spread":0.23414086820015637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073605475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921989,0.001676068,0.0000018204502,0.003941975,0.00027472936,0.00031628087,0.000014723078,0.000017339567,0.0015582049],"genre_scores_gemma":[0.9907345,0.0033720154,0.00007870523,0.0007757001,0.00040745537,0.00002464871,0.000042029005,0.000018926637,0.0045459997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871516,0.000046488443,0.00023476047,0.00044208815,0.000168574,0.0003929174],"domain_scores_gemma":[0.99933714,0.000012216315,0.000091963455,0.00042048536,0.000072768504,0.00006543788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025521714,0.00020239557,0.00018046351,0.00003892497,0.00011777329,0.000043702632,0.00029700284,0.00007426812,0.00005198804],"category_scores_gemma":[0.000036327354,0.00014285554,0.00007842073,0.00016846575,0.000051831947,0.000006588505,0.00017720181,0.00017636285,0.0000132923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121198806,0.00011726036,0.0018421861,0.00002185979,0.000034728797,0.0000057674256,0.00004669338,0.00002839514,0.95074594,0.00006718463,0.004421255,0.042547558],"study_design_scores_gemma":[0.0005591621,0.00017746873,0.0066582686,0.000014024326,0.00001300071,0.000005560653,0.000042398548,0.000046972946,0.9665404,0.0001057845,0.025602875,0.00023410207],"about_ca_topic_score_codex":0.0006837255,"about_ca_topic_score_gemma":0.0004508602,"teacher_disagreement_score":0.042313457,"about_ca_system_score_codex":0.00002493892,"about_ca_system_score_gemma":0.00006120873,"threshold_uncertainty_score":0.58254796},"labels":[],"label_agreement":null},{"id":"W2074635429","doi":"10.1097/cad.0b013e32831fb500","title":"Sorafenib tosylate in advanced kidney cancer: past, present and future","year":2009,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sorafenib; Medicine; Sunitinib; Kidney cancer; Oncology; Internal medicine; Cancer; Pharmacology; Clinical trial; Population; Hepatocellular carcinoma","score_opus":0.026817686603057903,"score_gpt":0.3380587351365086,"score_spread":0.3112410485334507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074635429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014242496,0.98812157,4.8885835e-7,0.005221721,0.00058809895,0.0023893989,0.00016551098,0.000074172756,0.0020147695],"genre_scores_gemma":[0.00012994451,0.9898813,0.0001278851,0.0006902874,0.0041698306,0.0006996028,0.00023627881,0.00012155143,0.003943356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967428,0.00013400464,0.00083356845,0.0010741183,0.00049723504,0.00071826414],"domain_scores_gemma":[0.9981697,0.000056412682,0.00043094167,0.0007416183,0.00009035208,0.0005109735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015254485,0.00088491244,0.0030622203,0.00034977982,0.00007286075,0.000042698324,0.00022649438,0.0004594725,0.0002493788],"category_scores_gemma":[0.000005519193,0.0006568344,0.00048762572,0.0005879885,0.000087446504,0.00013079122,0.000108349894,0.00080156524,0.00003999771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006218745,0.00014731193,0.0003049749,0.011669968,0.00029821348,0.00023121851,0.00022891515,0.0000022397207,0.000008216634,0.0000071585355,0.012029504,0.9750101],"study_design_scores_gemma":[0.0020629035,0.00016313988,0.0009472181,0.01835271,0.0014708911,0.000058087597,0.00003883758,0.000004461132,0.000079079604,0.000011088625,0.97625655,0.0005550299],"about_ca_topic_score_codex":0.00054043543,"about_ca_topic_score_gemma":0.000037097685,"teacher_disagreement_score":0.97445506,"about_ca_system_score_codex":0.0007660861,"about_ca_system_score_gemma":0.0010342925,"threshold_uncertainty_score":0.9995883},"labels":[],"label_agreement":null},{"id":"W2075303283","doi":"10.1097/cad.0b013e3280bad82d","title":"Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Furin; Recombinant DNA; Prostate cancer; Antigen; Proteases; Prostate; Prostate-specific antigen; Molecular biology; Biology; Chemistry; Cancer research; Biochemistry; Immunology; Cancer; Enzyme; Gene","score_opus":0.01737186353691626,"score_gpt":0.27205147427805304,"score_spread":0.25467961074113676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075303283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255496,0.001153978,0.00015668807,0.0006169793,0.00018462543,0.0024608704,0.000053035546,0.00014949853,0.0026693856],"genre_scores_gemma":[0.9947335,0.0023878,0.0007042306,0.00046820418,0.000255571,0.000120354925,0.000013611882,0.000057867157,0.0012588338],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758625,0.00012013595,0.00041717658,0.0007153565,0.0004193873,0.0007416921],"domain_scores_gemma":[0.9987822,0.000110560686,0.00018384836,0.00033980113,0.00032605446,0.00025749905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010137716,0.00035723066,0.0006667388,0.00015529226,0.0003240797,0.000039162784,0.000057627476,0.00013713297,0.000044128745],"category_scores_gemma":[0.00006157701,0.00031221347,0.00010229639,0.00043144592,0.00026687531,0.00019594787,0.00011367928,0.0004296126,0.000046998965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005773262,0.0005094115,0.5575903,0.00022579508,0.00011944643,0.0002292195,0.0035692228,0.0000014114084,0.42405125,0.00002709896,0.0029685558,0.010130973],"study_design_scores_gemma":[0.0015151516,0.00027413457,0.3977004,0.00014465899,0.000054015673,0.0000164884,0.00023114364,0.00006117621,0.5956375,0.000026051759,0.0040241955,0.00031508933],"about_ca_topic_score_codex":0.0028126768,"about_ca_topic_score_gemma":0.001853153,"teacher_disagreement_score":0.17158625,"about_ca_system_score_codex":0.00026472326,"about_ca_system_score_gemma":0.00019325326,"threshold_uncertainty_score":0.999933},"labels":[],"label_agreement":null},{"id":"W2076804008","doi":"10.1097/cad.0b013e328011a532","title":"Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Neutropenia; Febrile neutropenia; Chemotherapy; Absolute neutrophil count; Internal medicine; Surgery","score_opus":0.007428577568633091,"score_gpt":0.28579257432618876,"score_spread":0.2783639967575557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076804008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494594,0.0011780751,0.000108042375,0.0008047566,0.00008999037,0.00053396734,0.000025519494,0.00003232496,0.0022813696],"genre_scores_gemma":[0.9938991,0.0047513684,0.00015527208,0.0004470283,0.0002059557,0.000028170665,0.0000089585055,0.000034493518,0.00046964185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988747,0.000017390086,0.00028534202,0.00031563584,0.00020349829,0.00030340554],"domain_scores_gemma":[0.99940085,0.000060193775,0.00013927066,0.00021054325,0.00008607508,0.00010304309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015317179,0.00017566602,0.0004025873,0.00014358417,0.00006768525,0.000009612856,0.00007007945,0.000071367314,0.000333698],"category_scores_gemma":[0.000008435329,0.00013999565,0.000050412895,0.00041510013,0.00015821181,0.00009531819,0.000023897263,0.00022994514,0.0000020116472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008161952,0.00013750874,0.92964834,0.00004455011,0.00020264764,0.0000037675575,0.00095276645,0.000069013724,0.009451432,0.000036054204,0.00018247086,0.058455247],"study_design_scores_gemma":[0.0056675784,0.00012956657,0.94233996,0.0004253654,0.00009993147,0.000025435527,0.00012234904,0.000009424701,0.04945658,0.0000052053338,0.0015580824,0.00016054533],"about_ca_topic_score_codex":0.002754724,"about_ca_topic_score_gemma":0.00060708204,"teacher_disagreement_score":0.058294702,"about_ca_system_score_codex":0.0001095848,"about_ca_system_score_gemma":0.00016215071,"threshold_uncertainty_score":0.57088566},"labels":[],"label_agreement":null},{"id":"W2078410820","doi":"10.1097/cad.0000000000000043","title":"Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells","year":2013,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"ABCC1; Abcg2; Cytotoxicity; Efflux; Multiple drug resistance; SKBR3; Cytotoxic T cell; Viability assay; Pharmacology; ATP-binding cassette transporter; Biology; Cancer research; Cancer cell; Transporter; Cancer; Drug resistance; Apoptosis; In vitro; Biochemistry; Microbiology","score_opus":0.008272261964458742,"score_gpt":0.2499829644748366,"score_spread":0.24171070251037785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078410820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846513,0.0014363353,0.00025164167,0.0059030503,0.0006381696,0.0010075187,0.00026007698,0.00014918693,0.0018889026],"genre_scores_gemma":[0.98673236,0.0018838024,0.0007947274,0.003268996,0.0006058301,0.00025040438,0.000014067997,0.000092433576,0.006357393],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976537,0.000025342659,0.0004111019,0.0007003579,0.00048390188,0.0007255844],"domain_scores_gemma":[0.9985982,0.000028690425,0.00016684293,0.0004772014,0.0002005293,0.0005284885],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011857676,0.00041425237,0.0006890546,0.00017334029,0.00022770939,0.00010461358,0.00019004081,0.00017931119,0.0020191246],"category_scores_gemma":[0.0000036667896,0.00033826721,0.00015004881,0.00034490952,0.00012739866,0.00030819632,0.000059986905,0.00030958364,0.00022364763],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019325592,0.00023986139,0.060328092,0.0006808237,0.0002138296,0.000059523103,0.0019719189,0.000058553964,0.9058975,0.00009511544,0.012001784,0.018259758],"study_design_scores_gemma":[0.004040991,0.00009668406,0.51116645,0.0032475889,0.00036826057,0.000043632303,0.0022523997,0.00023896295,0.4588948,0.00015413729,0.018403167,0.0010929316],"about_ca_topic_score_codex":0.0019794907,"about_ca_topic_score_gemma":0.00021637544,"teacher_disagreement_score":0.45083836,"about_ca_system_score_codex":0.00014349812,"about_ca_system_score_gemma":0.00016432497,"threshold_uncertainty_score":0.99990696},"labels":[],"label_agreement":null},{"id":"W2080071903","doi":"10.1097/01.cad.0000203388.68034.06","title":"Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Laminin; MAPK/ERK pathway; Protein kinase A; Biology; Molecular biology; Cell growth; Cell adhesion; Cell biology; Cell surface receptor; Kinase; Extracellular; Extracellular matrix; Cell; Biochemistry","score_opus":0.008405670631498089,"score_gpt":0.23132277821791158,"score_spread":0.2229171075864135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080071903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943372,0.0020688307,0.0020269703,0.0002559142,0.00019105223,0.00034169256,0.00017258902,0.000022409862,0.00058333884],"genre_scores_gemma":[0.99659413,0.0006106698,0.0006943276,0.00020495846,0.00029744624,0.000033762266,0.00051616365,0.000038524144,0.001010037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850297,0.00015531918,0.00039367637,0.000397423,0.00024521773,0.00030537034],"domain_scores_gemma":[0.9991725,0.000024201412,0.0003053854,0.0003155144,0.00013641706,0.000045966357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033458826,0.00022359655,0.00024129137,0.000028900131,0.0001420058,0.000032729607,0.00016370488,0.000123479,0.0000895416],"category_scores_gemma":[0.000017380544,0.00018565655,0.00013258964,0.00014292372,0.00012271148,0.000019786241,0.00007463825,0.000118478005,0.000016479555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003984652,0.000090734386,0.00018330509,0.0000621615,0.000027911043,7.7736223e-7,0.00009878652,0.0003019178,0.9858828,0.00003783119,0.013096299,0.00017760666],"study_design_scores_gemma":[0.00071716314,0.0001477975,0.000052524352,0.000086172964,0.00004177276,0.0000014267448,0.00029987935,0.000114462026,0.9941806,0.00015598284,0.00396447,0.00023770412],"about_ca_topic_score_codex":0.00054968736,"about_ca_topic_score_gemma":0.000020565567,"teacher_disagreement_score":0.009131829,"about_ca_system_score_codex":0.00002259222,"about_ca_system_score_gemma":0.00008753,"threshold_uncertainty_score":0.75708544},"labels":[],"label_agreement":null},{"id":"W2087125925","doi":"10.1097/cad.0b013e3283349994","title":"Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study","year":2010,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ifosfamide; Docetaxel; Mesna; Cisplatin; Medicine; Nitrogen mustard; Chemotherapy; Toxicity; Pharmacology; Urology; Oncology; Anesthesia; Surgery; Internal medicine; Cyclophosphamide","score_opus":0.01912291119158156,"score_gpt":0.36763053314770044,"score_spread":0.3485076219561189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087125925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939258,0.00023140773,0.0000028809136,0.00077027513,0.00033035455,0.00077964726,0.000021354677,0.00005712985,0.0038811404],"genre_scores_gemma":[0.99698037,0.0004713331,0.000037457292,0.0002810625,0.00030136737,0.00020673995,0.0000068632417,0.00002814033,0.0016866544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988933,0.000029688328,0.0002602824,0.00037185842,0.0001559873,0.00028886125],"domain_scores_gemma":[0.9994228,0.00003638966,0.000067900146,0.00027814813,0.000047817062,0.00014695471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011378338,0.00019980659,0.0004119115,0.00015475781,0.00010702479,0.000036672314,0.000058164456,0.000059761136,0.0004159277],"category_scores_gemma":[0.000012755792,0.00016162562,0.00006248527,0.00026735174,0.00007458173,0.00013089366,0.000030202273,0.00028609013,0.0000421183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040804557,0.0046795444,0.6672315,0.000055934386,0.00022672345,0.00021451392,0.0055995863,0.0000065998834,0.26912707,0.00014802146,0.00082876626,0.0514737],"study_design_scores_gemma":[0.059950292,0.004060152,0.76223195,0.00021553815,0.0008946118,0.00021937625,0.0038790973,0.00030335516,0.14492765,0.00018611678,0.022328088,0.0008037597],"about_ca_topic_score_codex":0.0017886859,"about_ca_topic_score_gemma":0.0019165467,"teacher_disagreement_score":0.12419942,"about_ca_system_score_codex":0.00007453179,"about_ca_system_score_gemma":0.00015642184,"threshold_uncertainty_score":0.65909016},"labels":[],"label_agreement":null},{"id":"W2088169167","doi":"10.1097/cad.0b013e328331178f","title":"Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale","keywords":"Docetaxel; Medicine; Internal medicine; Oncology; Hazard ratio; Breast cancer; Chemotherapy; Metastatic breast cancer; Trastuzumab; Univariate analysis; Cancer; Proportional hazards model; Confidence interval; Multivariate analysis","score_opus":0.014285805433521878,"score_gpt":0.33397448165097277,"score_spread":0.3196886762174509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088169167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976827,0.00046959164,0.0000052458067,0.0016337617,0.00013137689,0.0071231104,0.00019097385,0.00008985265,0.0005878341],"genre_scores_gemma":[0.9938578,0.0031339559,0.00017778084,0.00063874276,0.00015004494,0.0015258795,0.000022318527,0.0000926162,0.00040084662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954588,0.00016919899,0.00069821643,0.0011524174,0.0013136513,0.0012077164],"domain_scores_gemma":[0.9980832,0.00008606771,0.0002572225,0.0006672236,0.00059571303,0.00031062015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044594952,0.0005500986,0.0011270441,0.00042982041,0.00011927492,0.00005351597,0.00031013016,0.00013078592,0.0003490452],"category_scores_gemma":[0.00005592607,0.00043703153,0.00008808972,0.0016907728,0.00018976093,0.00045263133,0.00006368823,0.0007991,0.0000141029295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005803773,0.0035476214,0.910733,0.0000629964,0.00016019758,0.000076249904,0.0041216537,0.00019884972,0.000093857045,0.0000026093448,0.00007466297,0.075124525],"study_design_scores_gemma":[0.027643915,0.0035753998,0.96553385,0.00075626135,0.00004013214,0.0000027684234,0.0005831208,0.00013327325,0.000937725,0.000042318643,0.00026814576,0.00048310796],"about_ca_topic_score_codex":0.018437259,"about_ca_topic_score_gemma":0.015302919,"teacher_disagreement_score":0.074641414,"about_ca_system_score_codex":0.0019473297,"about_ca_system_score_gemma":0.0009561047,"threshold_uncertainty_score":0.99980813},"labels":[],"label_agreement":null},{"id":"W2093477091","doi":"10.1097/00001813-200402000-00010","title":"Evaluation of antineoplastic action of 5-aza-2???-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Docetaxel; Cancer research; Carcinoma; Oncology; Breast carcinoma; Clonogenic assay; Medicine; Internal medicine; Biology; Cancer; Cell culture; Breast cancer","score_opus":0.03415982134665608,"score_gpt":0.3221899053774003,"score_spread":0.2880300840307442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093477091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995412,0.0026963647,0.00007832963,0.00030851574,0.00016917006,0.0008312607,0.00008183611,0.00002963874,0.00039290375],"genre_scores_gemma":[0.9987933,0.0007109453,0.000107847256,0.000052951164,0.00013726432,0.000033989458,0.000040897216,0.000041732244,0.000081075246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981906,0.00006464623,0.00042842506,0.00041211836,0.0006668319,0.00023737605],"domain_scores_gemma":[0.99873847,0.000029551215,0.00033961603,0.00027895242,0.0005071252,0.000106267486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042550586,0.00023836557,0.00045482334,0.00023439813,0.00007513649,0.000012043006,0.000052370986,0.00011975934,0.00004076422],"category_scores_gemma":[0.000035566714,0.0002225224,0.00007711958,0.00026423362,0.00014934978,0.00011823517,0.000042058946,0.0001950278,0.0000021700798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034505373,0.0003184579,0.018305006,0.0010187522,0.0001517581,0.00000877927,0.0010187877,0.0013177892,0.96674496,0.00005166954,0.0000781868,0.010640805],"study_design_scores_gemma":[0.009665232,0.00052943296,0.15511394,0.0008522721,0.001139904,0.000074410484,0.00016392891,0.0025660074,0.82953614,0.00009000336,0.000037904883,0.00023079883],"about_ca_topic_score_codex":0.0008132314,"about_ca_topic_score_gemma":0.00008305652,"teacher_disagreement_score":0.13720879,"about_ca_system_score_codex":0.00016551442,"about_ca_system_score_gemma":0.00034766996,"threshold_uncertainty_score":0.90742004},"labels":[],"label_agreement":null},{"id":"W2315916150","doi":"10.1097/00001813-200209000-00013","title":"Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cancer research; Clonogenic assay; Histone deacetylase; Acetylation; Phenylbutyrate; Histone; Carcinogenesis; DNA methylation; Chemistry; Trichostatin A; Gene silencing; Lung cancer; Biology; Molecular biology; DNA; Cell; Gene expression; Biochemistry; Gene; Medicine; Internal medicine","score_opus":0.030471060557525152,"score_gpt":0.29639497834369294,"score_spread":0.2659239177861678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315916150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610615,0.0022619707,0.00016141369,0.0000687504,0.00018456137,0.00011808779,0.000027176446,0.0000081195,0.001063758],"genre_scores_gemma":[0.99588984,0.0027991678,0.00006203102,0.00005390648,0.0002314421,0.000008799998,0.000029715324,0.000021974158,0.00090313656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991608,0.000036379402,0.00020240391,0.00029985677,0.00012136603,0.00017914247],"domain_scores_gemma":[0.99951535,0.000014050057,0.00013195613,0.00021623023,0.000066390516,0.0000559989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084023566,0.0001456472,0.00016286905,0.000055394103,0.00008724378,0.000015236746,0.00007573807,0.000102989296,0.00005027295],"category_scores_gemma":[0.000009901881,0.00014243399,0.00005353108,0.000078784324,0.000062975814,0.000005071371,0.000041774227,0.00006966865,0.0000051859447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016383985,0.00012617942,0.01109238,0.000054173168,0.000026677893,6.4910876e-7,0.00008502647,0.00009463033,0.98566896,0.00003349964,0.00040400674,0.0023974597],"study_design_scores_gemma":[0.0010533042,0.00018877214,0.011460782,0.000022825094,0.000030524556,4.6162137e-7,0.000029246481,0.00088219997,0.98409843,0.000017186649,0.0020553744,0.00016091065],"about_ca_topic_score_codex":0.00007807142,"about_ca_topic_score_gemma":0.000018677789,"teacher_disagreement_score":0.002236549,"about_ca_system_score_codex":0.00001082358,"about_ca_system_score_gemma":0.0000121378,"threshold_uncertainty_score":0.5808289},"labels":[],"label_agreement":null},{"id":"W2316570582","doi":"10.1097/cad.0b013e32835cbde7","title":"Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal; Université de Sherbrooke","funders":"","keywords":"Bone morphogenetic protein; Phosphorylation; Osteosarcoma; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Chemistry; Kinase; Protein kinase A; Bone morphogenetic protein 2; SMAD; Cell biology; Bone morphogenetic protein 7; Cancer research; Mitogen-activated protein kinase; Molecular biology; Biology; Biochemistry; In vitro","score_opus":0.015435058045119032,"score_gpt":0.2940673297100402,"score_spread":0.27863227166492116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316570582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709314,0.0022746779,0.0000381629,0.00011385543,0.000046434172,0.00035361614,0.00001708909,0.000008373894,0.00005466706],"genre_scores_gemma":[0.99885577,0.00005808736,0.00029339903,0.00016455018,0.00018037275,0.00008723599,0.000009606801,0.000016459768,0.00033454807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991432,0.000115497045,0.00019436881,0.00019021837,0.00014346033,0.00021328678],"domain_scores_gemma":[0.9994584,0.000031245723,0.00013425562,0.00025102065,0.000058758043,0.0000663515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026966844,0.00011457303,0.00011604105,0.000037868173,0.00015208339,0.000019448382,0.00014785568,0.000053827804,0.000018395156],"category_scores_gemma":[0.00005991181,0.00009042401,0.00004267886,0.00008839962,0.000098410615,0.0000098857645,0.00012613984,0.000049959996,0.000002517207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004527764,0.000052398023,0.0271826,0.000043909262,0.000033036315,1.0541974e-7,0.0005299771,0.000026175177,0.9703208,0.000008118032,0.00014266743,0.0016149208],"study_design_scores_gemma":[0.00016593302,0.00007670857,0.065090135,0.000060384365,0.000023901719,7.7056995e-7,0.00020303753,0.0000016961123,0.9314703,0.000007893918,0.0027883693,0.00011090353],"about_ca_topic_score_codex":0.0001027857,"about_ca_topic_score_gemma":0.00001141437,"teacher_disagreement_score":0.03885055,"about_ca_system_score_codex":0.000007380717,"about_ca_system_score_gemma":0.000051684965,"threshold_uncertainty_score":0.3687384},"labels":[],"label_agreement":null},{"id":"W2320715667","doi":"10.1097/cad.0b013e32835c3561","title":"Influence of statistician involvement on reporting of randomized clinical trials in medical oncology","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Statistician; Randomized controlled trial; Medicine; Clinical trial; Quality (philosophy); Research design; MEDLINE; Family medicine; Medical physics; Internal medicine; Statistics; Pathology; Mathematics","score_opus":0.8004655031878927,"score_gpt":0.6628950613416558,"score_spread":0.1375704418462369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320715667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922793,0.00090490346,0.0019652832,0.00085826014,0.00046869012,0.0010616526,0.0000141123355,0.0000018557099,0.0024459239],"genre_scores_gemma":[0.9967861,0.00056288595,0.001373148,0.0007500516,0.00015427,0.000087501634,0.0000026222688,0.0000065937147,0.00027683607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.68838716,0.15346721,0.14347537,0.0013151519,0.012637448,0.00071767403],"domain_scores_gemma":[0.65924484,0.19982524,0.13466527,0.003588025,0.002133725,0.00054291775],"candidate_categories":["metaresearch","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7938466,0.00019943956,0.015708085,0.00036577138,0.00003152052,0.000033416363,0.0008970838,0.00017452803,0.004666073],"category_scores_gemma":[0.6784283,0.00009209415,0.0023420253,0.00080607407,0.00032150297,0.00014108425,0.00012633848,0.00025552153,0.00012707103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023517571,0.000991091,0.7667561,0.00024527716,0.0010715094,0.000011680102,0.0038821502,0.00062485394,0.0002355154,0.009896083,0.012329229,0.20160474],"study_design_scores_gemma":[0.1864819,0.00075101055,0.6510798,0.004028689,0.004532602,0.000010581457,0.008403187,0.02131704,0.0060611228,0.019166773,0.09673079,0.0014365371],"about_ca_topic_score_codex":0.00037086048,"about_ca_topic_score_gemma":0.000097442055,"teacher_disagreement_score":0.2001682,"about_ca_system_score_codex":0.000045164536,"about_ca_system_score_gemma":0.0004477607,"threshold_uncertainty_score":0.99890476},"labels":[],"label_agreement":null},{"id":"W2322915138","doi":"10.1097/cad.0b013e328351aa8c","title":"Biological evaluation of a new family of aminosteroids that display a selective toxicity for various malignant cell lines","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Plant biochemistry and biosynthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Genome Canada","funders":"Canadian Institutes of Health Research; Health Canada; Cancer Research Society; Centre Hospitalier Universitaire de Québec; Cancer Research Institute","keywords":"Apoptosis; Cell culture; Cell growth; Cell cycle; Toxicity; LNCaP; Cell; Chemistry; Pharmacology; Cancer research; Biology; Cancer cell; Cancer; Biochemistry; Internal medicine; Medicine; Genetics","score_opus":0.04863013082892121,"score_gpt":0.29937959059144725,"score_spread":0.25074945976252605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322915138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581724,0.0025717677,0.00044120333,0.000039734463,0.0001144785,0.0003255253,0.00035563522,0.000005619229,0.00032881947],"genre_scores_gemma":[0.9983072,0.0005411263,0.00035372927,0.000090373855,0.00026836764,0.000040292114,0.00015790042,0.0000102029735,0.00023080762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989871,0.00006597304,0.00022569815,0.00026594527,0.00018971802,0.00026556037],"domain_scores_gemma":[0.99929357,0.000041391246,0.0002157395,0.00019236008,0.00018271038,0.00007424715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004418539,0.00016623552,0.00024997513,0.000023584302,0.000037692706,0.000005142309,0.0001609862,0.00021630403,0.000012235563],"category_scores_gemma":[0.00006855335,0.00012813465,0.0001402519,0.00007778487,0.00007433682,0.0000072787307,0.00006104307,0.00004419236,9.4998944e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019293302,0.00020010644,0.0157451,0.00006431432,0.0000789328,6.2937566e-8,0.00015084198,0.000009030437,0.97961354,0.0000053894264,0.001000541,0.0029391786],"study_design_scores_gemma":[0.0006661354,0.00017147863,0.013766761,0.000034541492,0.00012327805,0.0000020457428,0.00012970308,0.00008178487,0.9837335,0.000018519588,0.0011031312,0.00016914368],"about_ca_topic_score_codex":0.00008767115,"about_ca_topic_score_gemma":0.000008481208,"teacher_disagreement_score":0.004119908,"about_ca_system_score_codex":0.000017957165,"about_ca_system_score_gemma":0.00015168698,"threshold_uncertainty_score":0.5225179},"labels":[],"label_agreement":null},{"id":"W2324427724","doi":"10.1097/cad.0b013e328351c101","title":"Enhancement of the cytotoxic potential of the mixed EGFR and DNA-targeting ‘combi-molecule’ ZRBA1 against human solid tumour cells by a bis-quinazoline-based drug design approach","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Quinazolinone synthesis and applications","field":"Chemistry","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Quinazoline; Chemistry; Cytotoxic T cell; Apoptosis; Epidermal growth factor receptor; Tyrosine kinase; DNA; Flow cytometry; Molecular biology; Cancer research; Biology; Biochemistry; In vitro; Signal transduction; Receptor; Stereochemistry","score_opus":0.010916177647213534,"score_gpt":0.23779933724543956,"score_spread":0.22688315959822603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324427724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582,0.00072588114,0.0012507057,0.00026473036,0.00010216944,0.00042162315,0.00010628834,0.00002604141,0.0012825651],"genre_scores_gemma":[0.9984512,0.00012058521,0.0004785625,0.0001349954,0.00015786565,0.00015860576,0.000022289054,0.00005064633,0.00042525702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793166,0.00012939564,0.00060727354,0.00038020653,0.0004416943,0.00050974573],"domain_scores_gemma":[0.9984202,0.00007848427,0.0006483981,0.000655362,0.00009657868,0.000100995036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004554999,0.00031057297,0.0004181549,0.000035726884,0.00034100024,0.00003127269,0.00064151525,0.000109393724,0.000102607955],"category_scores_gemma":[0.000014309166,0.00021471355,0.00024312164,0.00022641246,0.00031194207,0.000080155005,0.00020302796,0.00024179144,0.000002908982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014418601,0.0006382461,0.00046244168,0.00020799754,0.000064079526,9.0702045e-8,0.00047716417,0.00017951152,0.99566096,0.00008349683,0.0019590585,0.000252543],"study_design_scores_gemma":[0.00067130104,0.000007962301,0.0003583494,0.00012610752,0.00009936066,4.827541e-7,0.00059643807,0.00092532014,0.99636656,0.000019266761,0.0005788906,0.00024998578],"about_ca_topic_score_codex":0.00014769465,"about_ca_topic_score_gemma":0.0000026065406,"teacher_disagreement_score":0.0026311977,"about_ca_system_score_codex":0.00006870262,"about_ca_system_score_gemma":0.0001252176,"threshold_uncertainty_score":0.87557644},"labels":[],"label_agreement":null},{"id":"W2325764269","doi":"10.1097/00001813-200303000-00008","title":"Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Doxorubicin; Pharmacokinetics; Metastatic breast cancer; Liposome; Medicine; Breast cancer; Pharmacology; Cyclophosphamide; Cancer; Chemotherapy; Chemistry; Internal medicine; Biochemistry","score_opus":0.013141340336735861,"score_gpt":0.2877310070471609,"score_spread":0.27458966671042506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325764269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943651,0.00068651926,0.00002347492,0.0010647313,0.00020882436,0.0022795354,0.0003336559,0.00005171781,0.000986435],"genre_scores_gemma":[0.9966899,0.00041608707,0.0003780544,0.00078719144,0.000040830397,0.00036093977,0.00044184824,0.00010081964,0.00078433217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639195,0.00035162788,0.00092239515,0.0007345309,0.00085576816,0.00074370025],"domain_scores_gemma":[0.99804956,0.00013264264,0.0006299334,0.00036568596,0.0005616494,0.00026050667],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000320213,0.00064218894,0.001309061,0.0005451621,0.00009951096,0.000031948548,0.00020999809,0.00012345849,0.0014627473],"category_scores_gemma":[0.000009755715,0.0004899518,0.0000974587,0.0012631638,0.00037592027,0.00031057565,0.000033448006,0.00057892257,0.000011295413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015167907,0.006114461,0.9590454,0.0005915101,0.0013591633,0.00014585047,0.003121013,0.0016194623,0.010953253,0.00016587027,0.0007498182,0.0009662953],"study_design_scores_gemma":[0.09384657,0.0034995829,0.8102924,0.0018501318,0.0013421213,0.00005578797,0.00084118836,0.0003255169,0.086306244,0.00011213247,0.0007402237,0.000788075],"about_ca_topic_score_codex":0.0059050545,"about_ca_topic_score_gemma":0.001986487,"teacher_disagreement_score":0.14875297,"about_ca_system_score_codex":0.0006095382,"about_ca_system_score_gemma":0.0009603845,"threshold_uncertainty_score":0.9997552},"labels":[],"label_agreement":null},{"id":"W2326174046","doi":"10.1097/cad.0000000000000212","title":"Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals","year":2015,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Medical Research Group","funders":"Genentech","keywords":"Erlotinib; Ranitidine; Pharmacology; Cmax; Pharmacokinetics; Medicine; Omeprazole; Erlotinib Hydrochloride; Tolerability; Proton-pump inhibitor; Gastroenterology; Internal medicine; Epidermal growth factor receptor; Adverse effect; Cancer","score_opus":0.023990155459102155,"score_gpt":0.39359497066074256,"score_spread":0.3696048152016404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326174046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075,0.0012740595,0.0000070608835,0.0013504139,0.00034026796,0.0007233305,0.00005935462,0.000029619729,0.0054658935],"genre_scores_gemma":[0.99771804,0.00053746573,0.000100037134,0.0008980071,0.0001567742,0.00010296863,0.00004051892,0.000023280581,0.0004229138],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886733,0.00008144862,0.00026521602,0.00021871344,0.00031855295,0.00024872992],"domain_scores_gemma":[0.9993569,0.00010577888,0.000116843265,0.00018549623,0.0000714157,0.00016352815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002835515,0.0001506256,0.00037419325,0.00019975778,0.000022484295,0.0000063934735,0.00006834394,0.000048867205,0.00007636345],"category_scores_gemma":[0.00003572667,0.00011490241,0.00006108616,0.00040940495,0.000042804193,0.000048911024,0.00001967249,0.00014266913,0.000034780485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021258937,0.001315087,0.8336638,0.0006828684,0.0004878767,0.000040041014,0.004802644,0.00062856294,0.002264169,0.00013307342,0.018603377,0.1352526],"study_design_scores_gemma":[0.15262397,0.033485297,0.33474475,0.0026750276,0.0033681856,0.000054399043,0.001316635,0.00073825486,0.36735076,0.00015479483,0.10226686,0.0012210582],"about_ca_topic_score_codex":0.00046770312,"about_ca_topic_score_gemma":0.000009453898,"teacher_disagreement_score":0.49891904,"about_ca_system_score_codex":0.0001975721,"about_ca_system_score_gemma":0.0003059739,"threshold_uncertainty_score":0.46855843},"labels":[],"label_agreement":null},{"id":"W2326269621","doi":"10.1097/00001813-200007000-00004","title":"Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Docetaxel; Taxane; Paclitaxel; Cytotoxicity; Kinase; Ovarian cancer; Cancer research; Medicine; Pharmacology; Oncology; Chemotherapy; Internal medicine; Chemistry; Cancer; In vitro; Breast cancer; Biochemistry","score_opus":0.012873713282393347,"score_gpt":0.3305387008184631,"score_spread":0.31766498753606975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326269621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887982,0.0005252724,0.0000028995873,0.0010870686,0.00013008386,0.0004584902,0.00029630988,0.00003151684,0.008670135],"genre_scores_gemma":[0.9861485,0.0008507774,0.00003260611,0.00043056547,0.00023314383,0.00004765289,0.000013586443,0.00002481629,0.012218357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998825,0.00004729145,0.00021165122,0.0003867402,0.0002024359,0.0003268509],"domain_scores_gemma":[0.9992845,0.00007510566,0.00009342998,0.00027505853,0.00004568548,0.0002262322],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060145416,0.00023519807,0.0004945555,0.0000962142,0.00006531775,0.0000122984575,0.00007243865,0.000055338696,0.0026107337],"category_scores_gemma":[0.000006193604,0.00018479116,0.00017109067,0.0001921904,0.00008981101,0.00006717035,0.000022428458,0.00015947307,0.000042264222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040485874,0.0051276945,0.056317136,0.0006965736,0.00092692405,0.00016594268,0.003289229,0.00009061207,0.74160695,0.000050644405,0.073660895,0.07758153],"study_design_scores_gemma":[0.014857137,0.0022375593,0.44450426,0.00026853688,0.00049891125,0.000006167731,0.000043112803,0.000066777095,0.5215535,0.00003038355,0.015504595,0.00042905603],"about_ca_topic_score_codex":0.0010184936,"about_ca_topic_score_gemma":0.00008643516,"teacher_disagreement_score":0.38818714,"about_ca_system_score_codex":0.00016632801,"about_ca_system_score_gemma":0.00013954361,"threshold_uncertainty_score":0.998301},"labels":[],"label_agreement":null},{"id":"W2326953798","doi":"10.1097/00001813-200304000-00005","title":"Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Cytotoxic T cell; Etoposide; Caveolin 1; Cancer cell; Drug; Doxorubicin; Drug resistance; Multiple drug resistance; Cancer; Biology; Cancer research; Cell culture; Pharmacology; Chemistry; Cell biology; In vitro; Chemotherapy; Biochemistry; Genetics","score_opus":0.00914706126737542,"score_gpt":0.26331468070040104,"score_spread":0.2541676194330256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326953798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959532,0.002414438,0.00021996116,0.00004541919,0.00029984966,0.00021254366,0.00009600985,0.00000731968,0.0007512429],"genre_scores_gemma":[0.99288327,0.0029677222,0.00004273296,0.00019534408,0.00009020559,0.00004618894,0.00010581835,0.000028824868,0.0036399204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987754,0.00008029335,0.0002865358,0.00040076644,0.00018354556,0.00027343704],"domain_scores_gemma":[0.9994057,0.000009414129,0.00016920519,0.0002379313,0.00011430556,0.00006344451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014771559,0.00018921887,0.00022930448,0.00005679491,0.000049831775,0.000011288186,0.000116779345,0.00014353899,0.00011224161],"category_scores_gemma":[0.000014216649,0.00018759788,0.00008253548,0.00016726665,0.00006738732,0.000010088916,0.000047465866,0.000091351525,0.0000064193428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046014393,0.00008045396,0.0023427573,0.000060321745,0.000023283299,9.2822853e-7,0.0003650607,0.0003059438,0.9897346,0.0000117696245,0.0063705305,0.0006583757],"study_design_scores_gemma":[0.00082995655,0.00002209866,0.0009162554,0.00008514146,0.000016077385,9.1695495e-7,0.00031471747,0.00004637443,0.9868864,0.000026942762,0.010635357,0.00021976381],"about_ca_topic_score_codex":0.00055572356,"about_ca_topic_score_gemma":0.00017996153,"teacher_disagreement_score":0.0042648274,"about_ca_system_score_codex":0.00003598434,"about_ca_system_score_gemma":0.00014244813,"threshold_uncertainty_score":0.76500195},"labels":[],"label_agreement":null},{"id":"W2327085958","doi":"10.1097/00001813-200008000-00012","title":"Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Letrozole; Anastrozole; Megestrol acetate; Medicine; Megestrol; Aromatase; Randomized controlled trial; Oncology; Hormonal therapy; Internal medicine; Quality-adjusted life year; Breast cancer; Quality of life (healthcare); Clinical trial; Aromatase inhibitor; Cancer; Gynecology; Cost effectiveness","score_opus":0.03360241873040829,"score_gpt":0.39322030578894535,"score_spread":0.35961788705853703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327085958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921433,0.0030680203,0.0000036521524,0.0013446832,0.00012134901,0.00086921616,0.002152175,0.000025358295,0.0002722779],"genre_scores_gemma":[0.9958246,0.0026665274,0.000086014334,0.000534622,0.00010253056,0.00023464378,0.00021154914,0.000022027167,0.00031751735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980337,0.000084720516,0.00073775736,0.0004495135,0.00031536928,0.0003789242],"domain_scores_gemma":[0.9990023,0.00007682818,0.00025209563,0.0003452887,0.00013591262,0.00018759821],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018406459,0.00027415276,0.0013040194,0.0004086943,0.000036602083,0.000005464842,0.00014631801,0.000074937736,0.007602059],"category_scores_gemma":[0.0000027491678,0.00024093193,0.00027495937,0.0015132203,0.0001371939,0.0001092755,0.000025763182,0.00020618613,0.0000073342753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006134512,0.0016678838,0.65132105,0.0000818834,0.0021475295,0.000009616671,0.0025529342,0.0059149773,0.059900716,0.0000030636907,0.0014440861,0.26882178],"study_design_scores_gemma":[0.013410077,0.00061681506,0.8027509,0.00014417198,0.0015577241,0.000003156126,0.0002548352,0.0033278537,0.17275092,0.000008735839,0.004887553,0.00028729468],"about_ca_topic_score_codex":0.006021175,"about_ca_topic_score_gemma":0.005048953,"teacher_disagreement_score":0.26853448,"about_ca_system_score_codex":0.00018986924,"about_ca_system_score_gemma":0.0002507999,"threshold_uncertainty_score":0.99330515},"labels":[],"label_agreement":null},{"id":"W2328178778","doi":"10.1097/cad.0000000000000132","title":"Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro","year":2014,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Government of Jiangsu Province","keywords":"Curcumin; Apoptosis; Mitochondrion; Glycolysis; Hexokinase; Cell biology; Cancer research; Protein kinase B; Intrinsic apoptosis; Anaerobic glycolysis; Chemistry; Cancer cell; Biology; Biochemistry; Programmed cell death; Metabolism; Cancer; Caspase; Genetics","score_opus":0.007410755609613626,"score_gpt":0.250974849820372,"score_spread":0.24356409421075836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328178778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312025,0.0046242857,0.000012012963,0.00025747556,0.0011593438,0.0004411452,0.00011029962,0.000019816944,0.000255364],"genre_scores_gemma":[0.99063253,0.006412217,0.00014086084,0.0006012962,0.0013799297,0.00033716197,0.00014279441,0.000050966708,0.00030221988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978089,0.00014093229,0.0004576963,0.0007980356,0.00021435469,0.00058007875],"domain_scores_gemma":[0.9992782,0.000028671026,0.00019250868,0.00030329073,0.00007548906,0.00012185309],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018973323,0.0003630374,0.00056438503,0.00016002852,0.00015711902,0.000044771372,0.00023776978,0.00032974867,0.00004800863],"category_scores_gemma":[0.00003803104,0.00037161226,0.00011764959,0.00044962048,0.00019484859,0.000030608113,0.0002142501,0.00025801922,0.000003921281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018714672,0.0001494129,0.00093946623,0.000042767842,0.000052670362,5.182671e-7,0.0009922358,0.000056265566,0.9922101,0.000011654481,0.0017115573,0.0036462063],"study_design_scores_gemma":[0.0028615845,0.000100586025,0.001690344,0.0000696195,0.000048450867,0.0000010046821,0.00017849088,0.00002844922,0.9542093,0.000022801078,0.040343903,0.00044544498],"about_ca_topic_score_codex":0.00566969,"about_ca_topic_score_gemma":0.002802185,"teacher_disagreement_score":0.03863235,"about_ca_system_score_codex":0.00007177565,"about_ca_system_score_gemma":0.00016725247,"threshold_uncertainty_score":0.9998736},"labels":[],"label_agreement":null},{"id":"W2329169495","doi":"10.1097/00001813-200203000-00002","title":"The role of DNA repair in nitrogen mustard drug resistance","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"RAD51; Nitrogen mustard; DNA repair; DNA damage; DNA; Homologous recombination; Cancer research; Biology; Homologous chromosome; Chemistry; Genetics; Gene; Chemotherapy","score_opus":0.011270867490387007,"score_gpt":0.27013716156457007,"score_spread":0.25886629407418305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329169495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019637807,0.99450195,0.0000014940732,0.000036020167,0.00021798775,0.00062424823,0.00015012301,0.000031075037,0.0024732964],"genre_scores_gemma":[0.00070146157,0.990142,0.00017671185,0.00004898149,0.00022868445,0.00025699046,0.00007627726,0.00008942585,0.008279475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975954,0.0002476042,0.0007285764,0.0006856615,0.00027640432,0.00046634875],"domain_scores_gemma":[0.9981532,0.000050281873,0.0004907727,0.0011463438,0.000090496156,0.00006889165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044821415,0.0004261419,0.0009666682,0.000081136095,0.00008792092,0.000016698661,0.0007172043,0.00033590966,0.000031871736],"category_scores_gemma":[0.00005062671,0.00032408972,0.00074407365,0.00028808758,0.00013548369,0.000004353668,0.00024715066,0.00027151624,0.000023340488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006672862,0.0002259164,0.000116406176,0.007830663,0.0010574785,0.000019118896,0.00029726585,0.0000028124202,0.005327074,0.00075892196,0.027907051,0.95639056],"study_design_scores_gemma":[0.00016898621,0.000017260134,6.7285913e-7,0.0017547562,0.00015887832,0.0000025281079,0.000074567404,0.0000028582297,0.019307842,0.00020314434,0.9779732,0.0003352769],"about_ca_topic_score_codex":0.000066339606,"about_ca_topic_score_gemma":0.0003265899,"teacher_disagreement_score":0.9560553,"about_ca_system_score_codex":0.000076158234,"about_ca_system_score_gemma":0.0002758407,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W2330927692","doi":"10.1097/cad.0000000000000096","title":"LC-based targeted metabolomics analysis of nucleotides and identification of biomarkers associated with chemotherapeutic drugs in cultured cell models","year":2014,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Drug action; Drug; Nucleotide; Mechanism of action; Pharmacology; Computational biology; Metabolomics; Biology; Chemistry; Biochemistry; Cancer research; Bioinformatics; In vitro; Gene","score_opus":0.006977960851828034,"score_gpt":0.2304244932160295,"score_spread":0.22344653236420148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330927692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578327,0.0021441162,0.0015318004,0.00007819964,0.000029801298,0.00015152693,0.000093019145,0.000006069364,0.00018221345],"genre_scores_gemma":[0.9973845,0.0016414479,0.0006318585,0.00008118289,0.0000105053905,0.000015878408,0.00014131969,0.000018318231,0.00007502293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998846,0.00008485147,0.00038421416,0.00034680543,0.00015261689,0.00018554408],"domain_scores_gemma":[0.999086,0.000028962151,0.00042211547,0.00026520388,0.00016358499,0.000034136687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040785543,0.00017080258,0.0005106337,0.00024748573,0.00003711718,0.000011850021,0.00013395818,0.00010118825,0.0000069743814],"category_scores_gemma":[0.000029387433,0.00014524517,0.00011896145,0.0007527702,0.00015228149,0.000008801426,0.00003399365,0.000051157946,1.1847569e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100136116,0.00014223401,0.020230703,0.00004225316,0.0016451282,3.4529563e-8,0.00028943623,0.0025632011,0.97435004,0.00011034391,0.000027600603,0.0004989167],"study_design_scores_gemma":[0.0012907205,0.000065703534,0.038202155,0.00001471375,0.00085874426,3.6033757e-8,0.00027061332,0.02203822,0.93689054,0.00007053336,0.00010236012,0.00019568061],"about_ca_topic_score_codex":0.00018340937,"about_ca_topic_score_gemma":0.00014073041,"teacher_disagreement_score":0.037459493,"about_ca_system_score_codex":0.000015330674,"about_ca_system_score_gemma":0.000040395596,"threshold_uncertainty_score":0.5922926},"labels":[],"label_agreement":null},{"id":"W2332257070","doi":"10.1097/00001813-200303000-00002","title":"Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3σ, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Depsipeptide; Cancer research; Carcinogenesis; DNA methylation; Histone deacetylase inhibitor; Breast carcinoma; Molecular biology; Chemistry; Epigenetics; Biology; Cancer; Histone deacetylase; Breast cancer; DNA; Histone; Gene expression; Gene; Biochemistry; Genetics","score_opus":0.008826567789554068,"score_gpt":0.26565926964723463,"score_spread":0.2568327018576806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332257070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991043,0.00017089809,0.00014805309,0.000027914135,0.000071692404,0.00031766016,0.000038538947,0.000003611045,0.00011731647],"genre_scores_gemma":[0.99933964,0.00019527084,0.0002834566,0.000008139928,0.000035255987,0.00003163728,0.000010995031,0.00001881701,0.00007676362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903977,0.000100604964,0.00028667296,0.0003226423,0.00011819136,0.00013210543],"domain_scores_gemma":[0.9993206,0.000043112854,0.00030984243,0.00018726962,0.00009318583,0.00004595465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001371132,0.00016655966,0.00027939756,0.00012509461,0.00004196817,0.000008490446,0.000047307065,0.000118608325,0.000014043574],"category_scores_gemma":[0.000056139907,0.00016381472,0.000033235174,0.00010291746,0.000121878635,0.000035842037,0.00006410259,0.00012913259,2.1104822e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022374102,0.00029089404,0.007510809,0.00020117151,0.000026055624,6.2854895e-7,0.00016166849,0.000022350801,0.9898192,0.000016677654,0.000022339995,0.0017044612],"study_design_scores_gemma":[0.001419015,0.00030096728,0.029158704,0.00029252036,0.00001997727,0.000008689413,0.00016855283,0.000023271772,0.968331,0.000013050266,0.00013210562,0.00013215237],"about_ca_topic_score_codex":0.00064154255,"about_ca_topic_score_gemma":0.00009054425,"teacher_disagreement_score":0.021647895,"about_ca_system_score_codex":0.000019164307,"about_ca_system_score_gemma":0.000035569694,"threshold_uncertainty_score":0.6680171},"labels":[],"label_agreement":null},{"id":"W2333316232","doi":"10.1097/cad.0b013e32834ea5b3","title":"Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Sorafenib; Clonogenic assay; Cancer research; Medicine; Annexin; Vascular endothelial growth factor; MAPK/ERK pathway; Apoptosis; Radiation therapy; In vivo; Cancer; Internal medicine; Pharmacology; Oncology; Hepatocellular carcinoma; Kinase; Biology; Immunology; VEGF receptors; Flow cytometry","score_opus":0.020607606022109204,"score_gpt":0.2677900791661434,"score_spread":0.2471824731440342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333316232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962121,0.0014989086,0.0006404101,0.001135282,0.0001266534,0.00022370086,0.00005279712,0.0000108625745,0.00009923837],"genre_scores_gemma":[0.9975791,0.0014916161,0.000077992445,0.000266115,0.00023524897,0.0001707596,0.0000329451,0.00003547903,0.00011072927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885976,0.00005455553,0.00017706973,0.00033977695,0.00015767544,0.00041118014],"domain_scores_gemma":[0.999561,0.000005009177,0.00011787955,0.00018478352,0.00006426877,0.0000670629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019899817,0.00019761565,0.00021994562,0.000104252875,0.000070990485,0.000033449192,0.00010995097,0.00014023307,0.00002677618],"category_scores_gemma":[0.0000027451144,0.00017584732,0.000061271814,0.00022403989,0.00006242394,0.00004850147,0.00004795832,0.000103760336,0.0000035839907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000172216,0.00021608744,0.66571623,0.00003509072,0.00004047462,0.0000011789821,0.00067306415,0.004846164,0.32061023,0.000026264292,0.00032488268,0.0073381215],"study_design_scores_gemma":[0.0023686984,0.000038254668,0.6860006,0.00011349603,0.000031323492,0.0000059574213,0.00012972018,0.007735693,0.30251846,0.000011486044,0.00062396826,0.0004223561],"about_ca_topic_score_codex":0.0015219781,"about_ca_topic_score_gemma":0.00046310155,"teacher_disagreement_score":0.020284371,"about_ca_system_score_codex":0.0001374396,"about_ca_system_score_gemma":0.00019017117,"threshold_uncertainty_score":0.7170846},"labels":[],"label_agreement":null},{"id":"W2333517888","doi":"10.1097/00001813-200301000-00004","title":"In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Sulfasalazine; In vitro; Inhibitory postsynaptic potential; Lymphoma; Cancer research; Pharmacology; Chemistry; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.047018581842425994,"score_gpt":0.3052550081109162,"score_spread":0.2582364262684902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333517888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991242,0.0006018227,6.190023e-7,0.0010050525,0.00013975934,0.000061063656,0.000011842664,0.000014534811,0.006923302],"genre_scores_gemma":[0.99852675,0.0006387436,0.000011147456,0.0002838904,0.000100984995,0.000045739394,0.0000011692505,0.000008098769,0.00038346273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910736,0.000102084814,0.00020238182,0.00021627433,0.00020984422,0.00016207609],"domain_scores_gemma":[0.99909395,0.00048017415,0.0001422599,0.00019032558,0.000074302014,0.00001897632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004712766,0.00012574346,0.00025022135,0.000025306761,0.000053963176,0.000006535292,0.000110924455,0.000078146564,0.00035928923],"category_scores_gemma":[0.00043614564,0.000073126794,0.00007947795,0.00013082723,0.00012218789,0.00005274361,0.000026447413,0.00007699326,0.000014195347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074227966,0.00021026739,0.002089498,0.000046784127,0.000047253456,9.581798e-7,0.00023566648,0.000004804809,0.9900983,0.00061236083,0.0005393869,0.006040481],"study_design_scores_gemma":[0.00037959285,0.000012713357,0.0030911092,0.00005649854,0.000013344879,2.857619e-7,0.00038650454,0.000027556813,0.99466527,0.00044884632,0.0008212241,0.00009706359],"about_ca_topic_score_codex":0.00006853328,"about_ca_topic_score_gemma":0.000007730823,"teacher_disagreement_score":0.00728476,"about_ca_system_score_codex":0.00009499241,"about_ca_system_score_gemma":0.000046352223,"threshold_uncertainty_score":0.3933965},"labels":[],"label_agreement":null},{"id":"W2333659151","doi":"10.1097/cad.0b013e328334992c","title":"Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer","year":2010,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Tranilast; Cancer research; Cell growth; Apoptosis; Cyclin D1; Cell cycle; Chemistry; Cyclin D; Medicine; Pharmacology; Biochemistry","score_opus":0.004213468023178503,"score_gpt":0.23211042846733235,"score_spread":0.22789696044415383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333659151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981904,0.0008340821,0.000015531527,0.00051577785,0.00008391845,0.0002398406,0.000064030915,0.000012105973,0.000044327004],"genre_scores_gemma":[0.998569,0.00061652565,0.00012004741,0.00013767219,0.00024028665,0.00010085128,0.00005517929,0.000019221136,0.0001412259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992567,0.000021916005,0.00015368305,0.00032241637,0.000086275395,0.00015902055],"domain_scores_gemma":[0.99968755,0.0000057355305,0.000060104354,0.00012165837,0.000059652953,0.000065301094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065020344,0.00013586809,0.00011308496,0.00004567979,0.00006217458,0.000043237782,0.000054418335,0.000105190185,0.000027684993],"category_scores_gemma":[0.000008712599,0.00012965106,0.000020800142,0.000071260896,0.00007038816,0.000014860445,0.000035797813,0.00009493534,9.969524e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039490038,0.00009117514,0.11232278,0.00007524488,0.000010007682,1.7114745e-7,0.00030155192,0.0000131593115,0.88272166,0.0000035336402,0.0001143263,0.0043068794],"study_design_scores_gemma":[0.0006225908,0.000033046446,0.08300978,0.000037553866,0.000016752636,0.0000026299338,0.000040681414,0.00014962036,0.9151571,0.000008518564,0.0007605348,0.00016118881],"about_ca_topic_score_codex":0.000360932,"about_ca_topic_score_gemma":0.0021689117,"teacher_disagreement_score":0.03243542,"about_ca_system_score_codex":0.000007202493,"about_ca_system_score_gemma":0.00008315989,"threshold_uncertainty_score":0.5287017},"labels":[],"label_agreement":null},{"id":"W2346252846","doi":"10.1097/cad.0000000000000366","title":"Pharmacokinetics of cabozantinib tablet and capsule formulations in healthy adults","year":2016,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada); Celerion (Canada)","funders":"","keywords":"Bioequivalence; Cabozantinib; Cmax; Pharmacokinetics; Medicine; Dosing; Capsule; Confidence interval; Pharmacology; Medullary thyroid cancer; Urology; Cancer; Internal medicine; Thyroid cancer","score_opus":0.015577115231370895,"score_gpt":0.31329053114583844,"score_spread":0.29771341591446754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346252846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948489,0.0013248789,0.000027890253,0.0021329932,0.000110751986,0.0004130512,0.00009559874,0.000022338332,0.0010235684],"genre_scores_gemma":[0.9931449,0.0054084817,0.00031598884,0.00033245276,0.000086561726,0.00003698295,0.000013910814,0.000020885642,0.00063980254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989729,0.000018153973,0.00031226446,0.0002423249,0.00017683709,0.00027751512],"domain_scores_gemma":[0.99944,0.00005724587,0.00011104428,0.0002132824,0.0000742398,0.00010419692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008432059,0.00012945541,0.00030781716,0.000112955306,0.000029324492,0.0000031410032,0.00005033635,0.000058187157,0.00025678775],"category_scores_gemma":[0.000024549441,0.000091831505,0.0000365883,0.00019583075,0.00007600462,0.000094751034,0.00003616318,0.00007838366,0.000012723968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022082592,0.00094949757,0.6577378,0.00117241,0.00030994712,0.00004560999,0.003924262,0.000025373718,0.10310004,0.0006753492,0.004365149,0.22548632],"study_design_scores_gemma":[0.09236228,0.0010817944,0.66457736,0.0028867943,0.0003209171,0.000042046067,0.00033477054,0.001648432,0.20382635,0.00014901336,0.032193214,0.00057704333],"about_ca_topic_score_codex":0.0015500385,"about_ca_topic_score_gemma":0.0001435207,"teacher_disagreement_score":0.22490928,"about_ca_system_score_codex":0.00021387708,"about_ca_system_score_gemma":0.00030409687,"threshold_uncertainty_score":0.374478},"labels":[],"label_agreement":null},{"id":"W2407413189","doi":"10.1097/00001813-200211002-00006","title":"Stem-cell transplantation in non-Hodgkinʼs lymphoma: improving outcome","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Autologous stem-cell transplantation; Medicine; Rituximab; Transplantation; Oncology; Stem cell; Minimal residual disease; Lymphoma; Follicular lymphoma; Internal medicine; Mantle cell lymphoma; Non-Hodgkin's lymphoma; Immunology; Leukemia; Biology","score_opus":0.04044046465829004,"score_gpt":0.3316298935328376,"score_spread":0.2911894288745476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407413189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050464016,0.9892082,0.000005909895,0.00006256178,0.000498544,0.0016896892,0.00020303448,0.00006426804,0.0032213943],"genre_scores_gemma":[0.011691821,0.984141,0.00007355796,0.00020255132,0.0002613735,0.00077733654,0.0002658003,0.00011317949,0.0024734014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708945,0.00008170376,0.0010850193,0.0007807943,0.0004072183,0.0005558077],"domain_scores_gemma":[0.99865097,0.00014750648,0.00045808606,0.00052607903,0.000047820275,0.00016952827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018364783,0.0006851291,0.0025209016,0.00038582375,0.00007056848,0.00004965808,0.00019829113,0.00040880466,0.00019863721],"category_scores_gemma":[0.0000023597001,0.00052420207,0.00070977164,0.00046327233,0.00004293522,0.00012806017,0.000036521935,0.00020943911,0.00037064817],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000116982455,0.0006509284,0.004043664,0.030224489,0.00015824285,0.00034654213,0.0003072371,6.6494067e-7,0.0000017893348,0.000005970261,0.0003332314,0.9639155],"study_design_scores_gemma":[0.010896041,0.0002211729,0.0055215955,0.028846476,0.006106493,0.0001585703,0.000092973016,0.00005190754,0.00019588026,0.0000017058461,0.9467538,0.0011533998],"about_ca_topic_score_codex":0.0011757695,"about_ca_topic_score_gemma":0.000051907526,"teacher_disagreement_score":0.9627621,"about_ca_system_score_codex":0.0010471542,"about_ca_system_score_gemma":0.00035086003,"threshold_uncertainty_score":0.99972093},"labels":[],"label_agreement":null},{"id":"W2567819266","doi":"10.1097/cad.0000000000000469","title":"Effect of dihydroartemisinin on UHRF1 gene expression in human prostate cancer PC-3 cells","year":2017,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artron Bioresearch (Canada)","funders":"Chongqing Municipal Education Commission","keywords":"DNMT1; Downregulation and upregulation; DNA methylation; Apoptosis; Cancer research; Cell cycle; Prostate cancer; Biology; Cancer cell; DNA methyltransferase; Methylation; Cancer; Molecular biology; Chemistry; Gene expression; Biochemistry; Gene; Genetics","score_opus":0.009098106776582633,"score_gpt":0.31571888425991645,"score_spread":0.30662077748333383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567819266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968208,0.001677514,0.000012863064,0.000072790695,0.00025078395,0.00028556498,0.000050380877,0.000005084267,0.00082422764],"genre_scores_gemma":[0.9957761,0.0029880835,0.000043630193,0.000030978077,0.00020023335,0.000074163676,0.000039189308,0.000028025119,0.0008195698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988887,0.00009284701,0.00024039575,0.00038279328,0.00016428398,0.00023103542],"domain_scores_gemma":[0.99902725,0.000015649102,0.000271022,0.0005868278,0.000044705215,0.0000545675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032437991,0.00017721437,0.00024079399,0.000046366244,0.00015168171,0.000031192147,0.00025565212,0.00013868016,0.000024437422],"category_scores_gemma":[0.000021940396,0.00015276512,0.00007936968,0.000034797595,0.00009031792,0.0000072398766,0.000107576525,0.00009625882,0.0000033606182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010253736,0.000044908724,0.038890164,0.000059573093,0.000015375015,0.000001279242,0.00012636957,0.00056384277,0.9518335,0.0000021643045,0.00016402142,0.008196256],"study_design_scores_gemma":[0.0011500994,0.00035967137,0.0100613525,0.00013968901,0.000013971913,6.0365934e-8,0.0000073614738,0.000034951838,0.98605365,0.000018596847,0.001988815,0.00017179326],"about_ca_topic_score_codex":0.0003906569,"about_ca_topic_score_gemma":0.00007440524,"teacher_disagreement_score":0.03422013,"about_ca_system_score_codex":0.00002110181,"about_ca_system_score_gemma":0.000041492836,"threshold_uncertainty_score":0.6229581},"labels":[],"label_agreement":null},{"id":"W2592985951","doi":"10.1097/cad.0000000000000493","title":"A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Eribulin; Capecitabine; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Clinical trial; Confidence interval; Retrospective cohort study; Cancer; Surgery","score_opus":0.04661719267652718,"score_gpt":0.4187347429406821,"score_spread":0.3721175502641549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592985951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029449366,0.994375,4.886851e-7,0.00028563643,0.00010236824,0.0028109965,0.0019722348,0.000010288978,0.00014852316],"genre_scores_gemma":[0.0014714987,0.9959885,0.000017792127,0.000103853396,0.000042461896,0.0010762347,0.00012808417,0.000038669925,0.0011329427],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99730676,0.0002582861,0.0014144849,0.0004861,0.00027538976,0.00025896553],"domain_scores_gemma":[0.99682474,0.00012098954,0.0020924227,0.0006256526,0.00024561357,0.0000905765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047175118,0.00046373607,0.010637749,0.0005953316,0.000038236518,0.000010626953,0.00020532482,0.00012597784,0.00063697307],"category_scores_gemma":[0.000054924916,0.0003265738,0.00086274464,0.0010918397,0.000228672,0.000102076556,0.00007449739,0.00025748453,0.0000027123708],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042051648,0.00017646236,0.0011976663,0.95339894,0.03092316,0.000020013393,0.00022964655,4.37096e-7,0.000003614066,0.000022740187,0.00017687307,0.013808393],"study_design_scores_gemma":[0.0010030479,0.000107220236,0.0019737808,0.55541193,0.4347702,0.000039456754,0.000037649424,0.0000056176136,0.000010966867,0.0000049952396,0.0063451123,0.00029001455],"about_ca_topic_score_codex":0.0023554733,"about_ca_topic_score_gemma":0.0007987909,"teacher_disagreement_score":0.403847,"about_ca_system_score_codex":0.0003666506,"about_ca_system_score_gemma":0.0006727533,"threshold_uncertainty_score":0.99991864},"labels":[],"label_agreement":null},{"id":"W2794034349","doi":"10.1097/cad.0000000000000589","title":"Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; QT interval; Placebo; Breast cancer; Dosing; Internal medicine; Anesthesia; Cardiology; Metastatic breast cancer; Cancer; Aromatase","score_opus":0.011148312293442708,"score_gpt":0.2969571145477851,"score_spread":0.2858088022543424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794034349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971677,0.00024974372,0.000030144496,0.00657366,0.00082655344,0.0012860192,0.0001219217,0.00011580779,0.0010793727],"genre_scores_gemma":[0.99166965,0.00020405576,0.00023239286,0.00589342,0.00085728744,0.00037705005,0.000018680024,0.00011685358,0.0006306297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705786,0.00016622567,0.00060535595,0.00077777175,0.0006781246,0.0007146837],"domain_scores_gemma":[0.99782765,0.00035352423,0.0003338466,0.00082712126,0.00048042682,0.00017743271],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041634933,0.00047840708,0.00077956996,0.00011764595,0.00019686586,0.000044079825,0.0003576662,0.00013471064,0.0009499173],"category_scores_gemma":[0.00009548712,0.00027739588,0.00016263242,0.00048710406,0.0007804992,0.0002420727,0.00010303826,0.0006472432,0.0002588575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021319052,0.0005854408,0.71183366,0.00013629877,0.00036834934,0.000013210312,0.0013431718,0.000037645346,0.0014166278,0.000051828873,0.0010144014,0.26188034],"study_design_scores_gemma":[0.017593395,0.0050704014,0.9452544,0.0031541095,0.00015871364,0.00000770648,0.00016195286,0.000102797756,0.004946396,0.000058996913,0.022865187,0.00062598294],"about_ca_topic_score_codex":0.00037955982,"about_ca_topic_score_gemma":0.00020454943,"teacher_disagreement_score":0.26125434,"about_ca_system_score_codex":0.00039095464,"about_ca_system_score_gemma":0.00028554664,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W2805530155","doi":"10.1097/cad.0000000000000661","title":"A case of severe Pembrolizumab-induced neutropenia","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Neutropenia; Immunosuppression; Adverse effect; Internal medicine; Immunology; Gastroenterology; Cancer; Chemotherapy; Immunotherapy","score_opus":0.02603540285744438,"score_gpt":0.3146937041468664,"score_spread":0.28865830128942205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805530155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861304,0.00055612205,0.0000040415885,0.0007471008,0.00043607136,0.00030760004,0.000027976788,0.000048318183,0.011742345],"genre_scores_gemma":[0.99577266,0.0003357018,0.00009938786,0.0011968883,0.00048724262,0.00002156943,0.000005599449,0.000031782594,0.0020491842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989239,0.00003066702,0.0003026025,0.00027789117,0.00018406131,0.00028087196],"domain_scores_gemma":[0.99913156,0.000024189509,0.00013910157,0.00041811503,0.00019429614,0.000092711336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013244365,0.00016886542,0.0003634896,0.00009710764,0.00009636379,0.000013257695,0.000107703854,0.00009504292,0.0012453579],"category_scores_gemma":[0.000009155416,0.00013924707,0.00015755858,0.00033210783,0.00019468437,0.000097217264,0.00004028894,0.00012609464,0.000054409164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065450734,0.00035484432,0.010738926,0.00034884625,0.00080494065,0.0007203136,0.004519548,8.3360516e-7,0.8261752,0.0002151558,0.016218513,0.13335782],"study_design_scores_gemma":[0.022672337,0.0021857342,0.040451005,0.0007174664,0.0005316422,0.00604406,0.0016494283,0.00013035395,0.8559225,0.000077909186,0.06879282,0.0008247411],"about_ca_topic_score_codex":0.0031338716,"about_ca_topic_score_gemma":0.00021982075,"teacher_disagreement_score":0.13253307,"about_ca_system_score_codex":0.00008323551,"about_ca_system_score_gemma":0.0002487588,"threshold_uncertainty_score":0.99966764},"labels":[],"label_agreement":null},{"id":"W2936620117","doi":"10.1097/cad.0000000000000685","title":"Cannabis-related cognitive impairment","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabis; Neurocognitive; Medicine; Psychiatry; Cognition; Anxiety; Effects of cannabis; Depression (economics); Effects of sleep deprivation on cognitive performance; Clinical psychology","score_opus":0.013207524565457915,"score_gpt":0.3263477358163184,"score_spread":0.31314021125086045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936620117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488288,0.0007738439,0.000012106771,0.02166346,0.00046674974,0.0007348545,0.00005460397,0.00011565912,0.027349902],"genre_scores_gemma":[0.8916419,0.00028868968,0.00001541775,0.0022108555,0.0006181687,0.00015537397,0.000031382468,0.000044808185,0.1049934],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980023,0.00004649671,0.00029843306,0.0004579895,0.0005594661,0.0006353284],"domain_scores_gemma":[0.99864954,0.000006599781,0.00007912974,0.00030642113,0.000625266,0.00033303048],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002759621,0.00021602998,0.00035473172,0.00016991272,0.00019727225,0.00003916844,0.00012562232,0.00012695549,0.0054718563],"category_scores_gemma":[0.000042131724,0.00017856921,0.00016825544,0.00053039554,0.00047778783,0.00009560429,0.00009719037,0.0003130466,0.0006647976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007034914,0.00069668196,0.02772871,0.0002090351,0.0005461628,0.000098394536,0.004604858,0.0000010788459,0.013078043,0.00038098622,0.8923014,0.059651196],"study_design_scores_gemma":[0.010030856,0.0023255951,0.29952663,0.00072066026,0.00037263174,0.000106051106,0.0032539647,0.00045156683,0.17290688,0.00017948674,0.5093263,0.000799402],"about_ca_topic_score_codex":0.0015008672,"about_ca_topic_score_gemma":0.000081227285,"teacher_disagreement_score":0.3829751,"about_ca_system_score_codex":0.00020534896,"about_ca_system_score_gemma":0.00060448644,"threshold_uncertainty_score":0.99543726},"labels":[],"label_agreement":null},{"id":"W2978014264","doi":"10.1097/cad.0000000000000653","title":"DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Docetaxel; Taxane; Paclitaxel; Medicine; Triple-negative breast cancer; Immunotherapy; Breast cancer; Pharmacology; Metastatic breast cancer; Chemotherapy; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.03358925432978724,"score_gpt":0.33690315042350005,"score_spread":0.30331389609371284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978014264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768506,0.006185541,0.00012461898,0.012186321,0.00046953393,0.0029513838,0.0010694141,0.00004065619,0.00012187486],"genre_scores_gemma":[0.9813159,0.010834622,0.00052110915,0.001900213,0.0006799502,0.0013133552,0.000013026778,0.000067593064,0.0033541906],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982521,0.000041833508,0.0004628415,0.000538666,0.00028864696,0.00041590774],"domain_scores_gemma":[0.99852467,0.00028493936,0.00022359412,0.00048757432,0.00036082487,0.00011841823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019327433,0.0003508182,0.00073746766,0.00009245209,0.00030012775,0.000054647484,0.00015934806,0.0001101248,0.00075511914],"category_scores_gemma":[0.000016851303,0.00019707439,0.00020495693,0.00038672567,0.00097127556,0.00009202993,0.000019181269,0.00008340012,0.0000058642563],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067821234,0.0022306906,0.08025618,0.0005443753,0.007489074,0.0000106659245,0.035958666,0.000006704679,0.19186014,0.000049887978,0.016257698,0.5975147],"study_design_scores_gemma":[0.036749348,0.011826733,0.28934625,0.0014105536,0.0013534176,0.00006337891,0.0024305482,0.00047243593,0.5001361,0.000032607488,0.15527512,0.00090351107],"about_ca_topic_score_codex":0.006879272,"about_ca_topic_score_gemma":0.00058210763,"teacher_disagreement_score":0.5966112,"about_ca_system_score_codex":0.0001707827,"about_ca_system_score_gemma":0.0005321138,"threshold_uncertainty_score":0.999734},"labels":[],"label_agreement":null},{"id":"W3048587704","doi":"10.1097/cad.0000000000000962","title":"A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways","year":2020,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences","keywords":"Triple-negative breast cancer; Cancer research; Breast cancer; Kinase; Metastasis; Cancer; Epithelial–mesenchymal transition; Phenotype; Biology; Cancer cell; Signal transduction; Medicine; Internal medicine; Cell biology; Gene; Genetics","score_opus":0.03351299110919341,"score_gpt":0.2767625854133924,"score_spread":0.24324959430419896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048587704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793854,0.0013839308,0.01744829,0.00037209757,0.000060568105,0.0010581077,0.00017717046,0.0000374585,0.000076988355],"genre_scores_gemma":[0.9921883,0.00007396426,0.0070302286,0.00040800837,0.00010776515,0.0001242168,0.000018099134,0.000045334953,0.0000041366097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818593,0.000082155,0.00031250104,0.000685636,0.00029956392,0.0004342394],"domain_scores_gemma":[0.999121,0.0000643599,0.00022369077,0.00019357285,0.00011374316,0.00028360583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018300809,0.0003521456,0.0008986415,0.00014788374,0.00007794227,0.000035459583,0.00012440205,0.0000858376,0.000019998339],"category_scores_gemma":[0.00003932553,0.00028320847,0.00011051241,0.0007338335,0.00012417344,0.00010766345,0.00014695337,0.00033120115,3.0934146e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001047676,0.00016525434,0.056406822,0.0010722334,0.00025644354,0.000041562147,0.0018334589,0.0061626784,0.9240253,0.000024657897,0.000018037379,0.0089459],"study_design_scores_gemma":[0.0048660436,0.0002632035,0.0910303,0.00061636284,0.00028005082,0.000009114569,0.00068210746,0.0033495862,0.89849645,0.000011376775,0.000017643159,0.00037778757],"about_ca_topic_score_codex":0.006614004,"about_ca_topic_score_gemma":0.00028220523,"teacher_disagreement_score":0.034623478,"about_ca_system_score_codex":0.00009462843,"about_ca_system_score_gemma":0.00016847816,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W3082347199","doi":"10.1097/cad.0000000000000951","title":"The positive correlation between drug addiction and drug dosage in vemurafenib-resistant melanoma cells is underpinned by activation of ERK1/2-FRA-1 pathway","year":2020,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Vemurafenib; Melanoma; Cancer research; Downregulation and upregulation; Medicine; Drug resistance; Pharmacology; clone (Java method); Drug; Addiction; Biology; Metastatic melanoma; Psychiatry; Genetics; Gene","score_opus":0.006785868286619531,"score_gpt":0.21391821300337346,"score_spread":0.20713234471675393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082347199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482656,0.0011394765,0.00047556244,0.0020986514,0.00010648122,0.00031669563,0.0003778718,0.000011956976,0.0006467346],"genre_scores_gemma":[0.99814,0.00050706445,0.00003361278,0.00057330524,0.00015359253,0.000024106515,0.00027809403,0.00002198474,0.00026825312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987882,0.00011496584,0.00031626798,0.00037165143,0.00017535042,0.00023355747],"domain_scores_gemma":[0.99936944,0.000068147005,0.0002247239,0.00018847956,0.00006420085,0.00008500814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017208568,0.00017678547,0.00020698196,0.000031964657,0.00013099753,0.00002872201,0.00012051341,0.000118996686,0.000012962165],"category_scores_gemma":[0.000018556093,0.0001497107,0.000073128416,0.0001462181,0.00008683655,0.000018637083,0.00007301059,0.0001380623,0.0000038349776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022269713,0.00003124243,0.009487733,0.000027968721,0.000101260186,9.0272397e-7,0.0012924079,0.00001935452,0.9743584,0.00012801848,0.008275157,0.0060548577],"study_design_scores_gemma":[0.00087557244,0.00011996321,0.015679829,0.000050995914,0.00003260249,2.438395e-7,0.0005760863,0.00016775803,0.9701827,0.000042996962,0.012086177,0.00018506004],"about_ca_topic_score_codex":0.0005168372,"about_ca_topic_score_gemma":0.00005883619,"teacher_disagreement_score":0.006192095,"about_ca_system_score_codex":0.000032626536,"about_ca_system_score_gemma":0.000078047124,"threshold_uncertainty_score":0.61050254},"labels":[],"label_agreement":null},{"id":"W4318967494","doi":"10.1097/cad.0000000000001429","title":"Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; Island Health","funders":"","keywords":"Duloxetine; Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Paclitaxel; Randomized controlled trial; Peripheral; Clinical trial; Internal medicine; Chemotherapy; Alternative medicine; Diabetes mellitus; Pathology","score_opus":0.027619715702373142,"score_gpt":0.3820460627967212,"score_spread":0.35442634709434806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318967494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059,0.0003405268,0.0000020022844,0.0025990426,0.0016370136,0.00413355,0.000044527278,0.000040229257,0.00061311224],"genre_scores_gemma":[0.996138,0.00045506444,0.00001550915,0.0008791087,0.00068280986,0.0008586362,0.000038413662,0.000050654882,0.0008818271],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958469,0.0015529835,0.0010705313,0.0005637647,0.0005508609,0.00041490598],"domain_scores_gemma":[0.99474186,0.0040983167,0.0005472855,0.00036810993,0.00010200236,0.0001424537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017116381,0.00032766288,0.0019173763,0.00019657258,0.00011704894,0.000009633079,0.00018585018,0.00009470114,0.0016107082],"category_scores_gemma":[0.0011257516,0.0002258205,0.00080372085,0.00032348474,0.00025019192,0.00004389578,0.000098543045,0.0006609233,0.000007519052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9554917,0.0037159182,0.0094339615,0.0002712909,0.0007401427,0.000085587744,0.0011548549,0.0000210923,0.021726377,0.000035746027,0.00096357096,0.006359754],"study_design_scores_gemma":[0.9130545,0.021478549,0.0039846054,0.00011039432,0.0020735243,0.000010582841,0.000091175054,0.0001893778,0.057400476,0.000020211797,0.0013269352,0.00025966775],"about_ca_topic_score_codex":0.00040126673,"about_ca_topic_score_gemma":0.0000133836675,"teacher_disagreement_score":0.042437203,"about_ca_system_score_codex":0.00018063952,"about_ca_system_score_gemma":0.00042960342,"threshold_uncertainty_score":0.99930197},"labels":[],"label_agreement":null},{"id":"W4390533628","doi":"10.1097/cad.0000000000001565","title":"Tumor neoantigens derived from RNA editing events show significant clinical relevance in melanoma patients treated with immunotherapy","year":2023,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Immunotherapy; Clinical significance; Melanoma; Medicine; Epitope; Antigen; Major histocompatibility complex; Immunology; Internal medicine; Oncology; Cancer research; Cancer","score_opus":0.014069221652476555,"score_gpt":0.28332261763742095,"score_spread":0.2692533959849444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390533628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998802,0.0002279128,0.0000340861,0.00016400697,0.00021188779,0.00026622834,0.00012743147,0.00003939834,0.00012702424],"genre_scores_gemma":[0.99723697,0.0009078341,0.00008680096,0.00044677453,0.0002705775,0.000049128044,0.00056310475,0.000040226405,0.00039858278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856526,0.00010631169,0.00036217764,0.00048568216,0.00017322887,0.00030735182],"domain_scores_gemma":[0.9992778,0.000038522336,0.000174828,0.00031553055,0.00008794594,0.000105428124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001236298,0.00018923984,0.00024066733,0.00005580296,0.00007145034,0.000020484393,0.00017331613,0.00009167745,0.00006136192],"category_scores_gemma":[0.000055690194,0.00016394744,0.00009977186,0.0002355989,0.00007342455,0.000010607116,0.000047412035,0.00009204216,0.000033470627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003320094,0.00016251301,0.8943261,0.000006538506,0.00007980485,0.000011644048,0.00006052563,0.00009828382,0.095161535,0.0000020667194,0.0008315758,0.008927427],"study_design_scores_gemma":[0.0030520642,0.00013032151,0.9379712,0.000058963407,0.0000151375,1.8202395e-7,0.00009178203,0.0003083335,0.055812564,0.000018057524,0.0023036061,0.00023782364],"about_ca_topic_score_codex":0.00028629377,"about_ca_topic_score_gemma":0.00008428401,"teacher_disagreement_score":0.043645088,"about_ca_system_score_codex":0.000021844735,"about_ca_system_score_gemma":0.00010055424,"threshold_uncertainty_score":0.66855824},"labels":[],"label_agreement":null},{"id":"W4399850500","doi":"10.1097/cad.0000000000001627","title":"Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells","year":2024,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada; Réseau Québécois de Recherche sur les Médicaments; Université du Québec à Montréal","keywords":"Vasculogenic mimicry; CTGF; CYR61; Hippo signaling pathway; Biology; Cancer research; Gene silencing; Angiogenesis; Small interfering RNA; Cell biology; Signal transduction; Cancer; Cell culture; Metastasis; Gene; Genetics; Transfection; Growth factor","score_opus":0.005938760881203694,"score_gpt":0.22194700000456552,"score_spread":0.21600823912336184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399850500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98266315,0.01634183,0.00016777056,0.00016470431,0.0002451889,0.00016877713,0.00016460105,0.000014614698,0.000069382186],"genre_scores_gemma":[0.9977697,0.0014887743,0.000081585444,0.00007215906,0.000113778326,0.000035153458,0.00007096372,0.000029455578,0.00033840348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878746,0.00007463657,0.00027246028,0.00044987068,0.00016531351,0.0002502632],"domain_scores_gemma":[0.9996766,0.000021696325,0.000050910494,0.00016813294,0.000029642846,0.000053058957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023251835,0.00018013288,0.00022460366,0.00013247582,0.00003011663,0.000023179462,0.00009767175,0.00018153546,0.000037001348],"category_scores_gemma":[0.0000065099525,0.00017909889,0.00011362257,0.00016368911,0.000101759186,0.000012237263,0.000029913554,0.00013174968,0.000005428447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001122603,0.00007031254,0.0004101491,0.00014825445,0.000042752614,0.0000034617412,0.00046409995,0.00008633402,0.9954487,0.0000135622495,0.00028817088,0.0029119097],"study_design_scores_gemma":[0.00055213616,0.00007894058,0.0007382529,0.00018413184,0.000024231273,0.000004840123,0.00008619813,0.00045801586,0.9914421,0.000055308436,0.006187873,0.00018799392],"about_ca_topic_score_codex":0.0001302208,"about_ca_topic_score_gemma":0.000061079045,"teacher_disagreement_score":0.015106594,"about_ca_system_score_codex":0.000030033312,"about_ca_system_score_gemma":0.000099281504,"threshold_uncertainty_score":0.73034406},"labels":[],"label_agreement":null},{"id":"W4401728325","doi":"10.1097/cad.0000000000001658","title":"Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"Ontario Genomics Institute; National Cancer Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ontario Genomics; Genome Canada; McGill University; Genentech; Bayer; Tulane University; Pfizer; Bristol-Myers Squibb","keywords":"Kinome; Cyclin-dependent kinase 4; Triple-negative breast cancer; Cancer research; Kinase; Cyclin-dependent kinase; Cyclin-dependent kinase 7; Biology; Cyclin-dependent kinase 2; Cyclin-dependent kinase 9; Cancer; Cell biology; Cell cycle; Breast cancer; Protein kinase A; Genetics","score_opus":0.018259640537071277,"score_gpt":0.2670174725904091,"score_spread":0.24875783205333782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401728325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658204,0.021039443,0.00083920185,0.002631317,0.002045685,0.0015156831,0.002911151,0.0003902562,0.0028068712],"genre_scores_gemma":[0.99247336,0.0020244482,0.001000349,0.00057818677,0.0006547998,0.0003095919,0.00013700346,0.00017581812,0.002646416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99691147,0.00006993412,0.0008053236,0.00088828354,0.00063877186,0.00068620295],"domain_scores_gemma":[0.99876267,0.00010525531,0.00021053114,0.00052426424,0.00013404532,0.00026321856],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027840032,0.00044973934,0.00083666947,0.0006721085,0.000082739956,0.000096174175,0.00023581348,0.00025949796,0.001471031],"category_scores_gemma":[0.000048291833,0.00043487316,0.00034357072,0.0019079929,0.00020395913,0.0007524453,0.00019246984,0.00076543627,0.00003433526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013893031,0.0007989368,0.0067739286,0.0021257747,0.00077836076,0.00074377604,0.0047063697,0.0007796144,0.9235031,0.0009780634,0.015360186,0.04206261],"study_design_scores_gemma":[0.010175859,0.00018588481,0.019325288,0.0103422655,0.00052315823,0.000078488425,0.0011414497,0.007420616,0.9366668,0.00019986257,0.012993359,0.00094696204],"about_ca_topic_score_codex":0.0058794306,"about_ca_topic_score_gemma":0.00030345545,"teacher_disagreement_score":0.04111565,"about_ca_system_score_codex":0.0002939277,"about_ca_system_score_gemma":0.001269636,"threshold_uncertainty_score":0.9998103},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"}]}